(+)-alpha-tocopherol decreases expression ISO RGD:2200 6480464 alpha-Tocopherol results in decreased expression of BCL2L1 protein CTD PMID:18942769 (+)-dexrazoxane increases expression EXP 6480464 Dexrazoxane results in increased expression of BCL2L1 mRNA CTD PMID:26873546 (+)-epicatechin-3-O-gallate increases expression ISO RGD:735516 6480464 epicatechin gallate results in increased expression of BCL2L1 protein alternative form CTD PMID:21945981 (+)-Tetrandrine decreases expression ISO RGD:735516 6480464 tetrandrine results in decreased expression of BCL2L1 protein CTD PMID:26822499 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735516 6480464 [arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:18348186 , PMID:20950636 (R)-carnitine multiple interactions ISO RGD:2200 6480464 Carnitine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] CTD PMID:19491382 (R)-lipoic acid multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 (R)-mevalonic acid multiple interactions ISO RGD:2200 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2L1 protein] CTD PMID:11178870 (R)-noradrenaline decreases expression ISO RGD:2200 6480464 Norepinephrine results in decreased expression of BCL2L1 mRNA CTD PMID:18675472 (R)-Salsolinol decreases expression ISO RGD:2200 6480464 salsolinol results in decreased expression of BCL2L1 protein CTD PMID:11502874 (S)-amphetamine affects expression ISO RGD:2200 6480464 Dextroamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 (S)-amphetamine decreases expression ISO RGD:735516 6480464 Dextroamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 (S)-amphetamine multiple interactions ISO RGD:735516 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 (S)-colchicine multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with Colchicine] results in decreased expression of BCL2L1 protein CTD PMID:11749691 (S)-naringenin decreases expression ISO RGD:735516 6480464 naringenin results in decreased expression of BCL2L1 protein CTD PMID:27838343 (S)-nicotine multiple interactions EXP 6480464 resveratrol inhibits the reaction [Nicotine results in decreased expression of BCL2L1 mRNA] CTD PMID:22687363 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BCL2L1 mRNA CTD PMID:22687363 1'-acetoxychavicol acetate multiple interactions ISO RGD:735516 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO RGD:2200 6480464 o, p'-DDT analog results in decreased expression of BCL2L1 mRNA CTD PMID:22937105 1,3-dinitrobenzene decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to 3-dinitrobenzene CTD PMID:10960601 1,3-dinitrobenzene decreases expression ISO RGD:2200 6480464 3-dinitrobenzene results in decreased expression of BCL2L1 mRNA CTD PMID:22841810 1,3-dinitrobenzene increases expression ISO RGD:2200 6480464 3-dinitrobenzene results in increased expression of BCL2L1 mRNA CTD PMID:16025311 1,3-dinitrobenzene affects response to substance ISO RGD:2200 6480464 BCL2L1 protein affects the susceptibility to 3-dinitrobenzene CTD PMID:16257055 1,3-Dinitropyrene decreases expression EXP 6480464 1, 3-dinitropyrene results in decreased expression of BCL2L1 protein CTD PMID:17240030 1-bromopropane decreases expression ISO RGD:735516 6480464 1-bromopropane results in decreased expression of BCL2L1 mRNA CTD PMID:16815550 1-bromopropane decreases expression ISO RGD:2200 6480464 1-bromopropane results in decreased expression of BCL2L1 mRNA CTD PMID:16815550 1-nitropyrene decreases expression EXP 6480464 1-nitropyrene results in decreased expression of BCL2L1 protein CTD PMID:17240030 10-Hydroxycamptothecin affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to 10-hydroxycamptothecin CTD PMID:17033717 17beta-estradiol affects expression ISO RGD:735516 6480464 Estradiol affects the expression of BCL2L1 mRNA CTD PMID:11896290 17beta-estradiol decreases expression ISO RGD:735516 6480464 Estradiol results in decreased expression of BCL2L1 mRNA CTD PMID:21632981 more ... 17beta-estradiol multiple interactions ISO RGD:735516 6480464 EGF protein promotes the reaction [Estradiol results in decreased expression of BCL2L1 mRNA] CTD PMID:24758408 17beta-estradiol increases expression ISO RGD:735516 6480464 Estradiol results in increased expression of BCL2L1 mRNA, Estradiol results in increased expression of BCL2L1 protein CTD PMID:15969986 more ... 17beta-estradiol multiple interactions ISO RGD:2200 6480464 Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] CTD PMID:14659978 17beta-estradiol 3-benzoate affects expression ISO RGD:2200 6480464 estradiol 3-benzoate affects the expression of BCL2L1 mRNA CTD PMID:15664431 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of BCL2L1 mRNA CTD PMID:17023530 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:2200 6480464 Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2L1 protein] CTD PMID:16407456 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:735516 6480464 2 more ... CTD PMID:27589474 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:735516 6480464 2 more ... CTD PMID:27589474 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one decreases expression ISO RGD:735516 6480464 2 more ... CTD PMID:21109480 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735516 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA CTD PMID:16039398 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BCL2L1 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L1 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735516 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L1 mRNA CTD PMID:12167310 , PMID:14718646 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2200 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L1 mRNA, Tetrachlorodibenzodioxin results in increased expression of BCL2L1 protein CTD PMID:15965093 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2200 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA, Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 protein CTD PMID:15965093 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA CTD PMID:19933214 2,4-dinitrotoluene affects expression ISO RGD:2200 6480464 2, 4-dinitrotoluene affects the expression of BCL2L1 mRNA CTD PMID:21346803 2,6-dichloroindophenol multiple interactions ISO RGD:735516 6480464 [2, 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in decreased expression of BCL2L1 mRNA CTD PMID:21034357 2-acetamidofluorene multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein, IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein] CTD PMID:11915028 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of BCL2L1 mRNA CTD PMID:21607683 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:735516 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 , PMID:16850161 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:735516 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 2-deoxy-D-glucose decreases response to substance EXP 6480464 BCL2L1 protein results in decreased susceptibility to Deoxyglucose CTD PMID:10679475 2-ethoxyethanol increases expression ISO RGD:2200 6480464 2-ethoxyethanol results in increased expression of BCL2L1 mRNA CTD PMID:19643169 2-methoxyethanol increases expression ISO RGD:2200 6480464 methyl cellosolve results in increased expression of BCL2L1 mRNA CTD PMID:19643169 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein CTD PMID:15987750 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:2200 6480464 Dinoprostone affects the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:16396944 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 [Puromycin Aminonucleoside co-treated with pifithrin] results in increased expression of BCL2L1 protein, Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:15987750 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression ISO RGD:2200 6480464 Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein CTD PMID:16396944 3,3',5-triiodo-L-thyronine increases expression ISO RGD:735516 6480464 Triiodothyronine results in increased expression of BCL2L1 protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine increases expression ISO RGD:2200 6480464 Triiodothyronine results in increased expression of BCL2L1 protein CTD PMID:16021636 3,3'-diindolylmethane increases expression ISO RGD:735516 6480464 3 more ... CTD PMID:18025290 3,4-methylenedioxymethamphetamine affects expression ISO RGD:2200 6480464 N-Methyl-3, 4-methylenedioxyamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:735516 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:735516 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 3,7-dihydropurine-6-thione decreases expression ISO RGD:735516 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 2 more ... CTD PMID:29704545 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] CTD PMID:19116755 3-methyladenine increases expression EXP 6480464 3-methyladenine results in increased expression of BCL2L1 mRNA CTD PMID:21681844 3-methyladenine multiple interactions ISO RGD:735516 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] CTD PMID:19116755 3-nitropropanoic acid decreases expression ISO RGD:2200 6480464 3-nitropropionic acid results in decreased expression of BCL2L1 mRNA CTD PMID:21827809 3-nitropropanoic acid multiple interactions ISO RGD:2200 6480464 Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2L1 mRNA] CTD PMID:21827809 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO RGD:735516 6480464 [4 more ... CTD PMID:16489027 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO RGD:735516 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide multiple interactions ISO RGD:735516 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2L1 protein CTD PMID:16187019 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of BCL2L1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:735516 6480464 Fenretinide results in decreased expression of BCL2L1 protein CTD PMID:16187019 4-nitro-m-cresol multiple interactions EXP 6480464 Quercetin inhibits the reaction [4-nitro-3-cresol results in decreased expression of BCL2L1 protein] CTD PMID:22467373 4-nitro-m-cresol decreases expression EXP 6480464 4-nitro-3-cresol results in decreased expression of BCL2L1 protein CTD PMID:22467373 4-nitrophenol decreases expression EXP 6480464 4-nitrophenol results in decreased expression of BCL2L1 protein CTD PMID:23997041 4-nitrophenol multiple interactions EXP 6480464 Quercetin inhibits the reaction [4-nitrophenol results in decreased expression of BCL2L1 protein] CTD PMID:23997041 4-nonylphenol decreases expression ISO RGD:2200 6480464 4-nonylphenol results in decreased expression of BCL2L1 mRNA, 4-nonylphenol results in decreased expression of BCL2L1 protein CTD PMID:27087316 , PMID:27109770 4-vinylcyclohexene dioxide increases expression EXP 6480464 4-vinyl-1-cyclohexene dioxide results in increased expression of BCL2L1 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine decreases expression ISO RGD:735516 6480464 Decitabine results in decreased expression of BCL2L1 protein CTD PMID:19372550 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735516 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of BCL2L1 mRNA CTD PMID:17064661 5-azacytidine multiple interactions ISO RGD:735516 6480464 [metacept-1 co-treated with Azacitidine] results in decreased expression of BCL2L1 CTD PMID:19148494 5-azacytidine affects expression ISO RGD:735516 6480464 [Azacitidine affects the expression of IL6R protein] which affects the expression of BCL2L1 protein CTD PMID:18443271 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of BCL2L1 protein CTD PMID:20844880 5-fluorouracil multiple interactions ISO RGD:2200 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA], Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:31129132 5-fluorouracil affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Fluorouracil CTD PMID:15767554 more ... 5-fluorouracil increases expression ISO RGD:735516 6480464 Fluorouracil results in increased expression of BCL2L1 mRNA, Fluorouracil results in increased expression of BCL2L1 protein CTD PMID:16557594 , PMID:19116755 5-fluorouracil decreases expression ISO RGD:735516 6480464 Fluorouracil results in decreased expression of BCL2L1 more ... CTD PMID:12442003 more ... 5-fluorouracil affects expression ISO RGD:735516 6480464 Fluorouracil affects the expression of BCL2L1 mRNA, Fluorouracil affects the expression of BCL2L1 protein CTD PMID:16929163 5-fluorouracil decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Fluorouracil CTD PMID:17439414 5-fluorouracil multiple interactions ISO RGD:735516 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] more ... CTD PMID:15289866 more ... 5-fluorouracil multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein], IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] CTD PMID:19116755 , PMID:20844880 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of BCL2L1 protein CTD PMID:19116755 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:21593185 8-OH-DPAT multiple interactions EXP 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] more ... CTD PMID:30366073 8-OH-DPAT decreases expression EXP 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein CTD PMID:30366073 9,10-anthraquinone decreases expression ISO RGD:735516 6480464 9, 10-anthraquinone analog results in decreased expression of BCL2L1 protein CTD PMID:26915975 [6]-Shogaol decreases expression ISO RGD:735516 6480464 shogaol results in decreased expression of BCL2L1 protein CTD PMID:18384088 acetochlor affects expression ISO RGD:735516 6480464 acetochlor affects the expression of BCL2L1 protein CTD PMID:25291404 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of BCL2L1 protein CTD PMID:20886344 acetylsalicylic acid increases expression ISO RGD:735516 6480464 Aspirin results in increased expression of BCL2L1 mRNA CTD PMID:17342322 , PMID:20457246 acrylamide affects expression ISO RGD:2200 6480464 Acrylamide affects the expression of BCL2L1 mRNA CTD PMID:28959563 actinomycin D decreases expression ISO RGD:735516 6480464 Dactinomycin results in decreased expression of BCL2L1 protein CTD PMID:15592511 actinomycin D multiple interactions ISO RGD:735516 6480464 Dexamethasone inhibits the reaction [Dactinomycin results in increased expression of BCL2L1 protein] CTD PMID:9326359 actinomycin D increases expression ISO RGD:735516 6480464 Dactinomycin results in increased expression of BCL2L1 protein, Dactinomycin results in increased expression of BCL2L1 protein alternative form CTD PMID:12430140 , PMID:9326359 adenosine decreases expression ISO RGD:735516 6480464 Adenosine results in decreased expression of BCL2L1 mRNA, Adenosine results in decreased expression of BCL2L1 protein CTD PMID:20063052 adenosine multiple interactions ISO RGD:735516 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 mRNA], Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 protein] CTD PMID:20063052 afimoxifene increases expression ISO RGD:735516 6480464 afimoxifene results in increased expression of BCL2L1 mRNA CTD PMID:19698761 aflatoxin B1 increases expression ISO RGD:735516 6480464 Aflatoxin B1 results in increased expression of BCL2L1 mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO RGD:735516 6480464 Aflatoxin B1 results in decreased expression of BCL2L1 mRNA CTD PMID:28943387 aflatoxin B1 decreases methylation ISO RGD:735516 6480464 Aflatoxin B1 results in decreased methylation of BCL2L1 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of BCL2L1 protein CTD PMID:26968497 AH23848 multiple interactions ISO RGD:735516 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2L1 protein] more ... CTD PMID:19407222 aldehydo-D-glucosamine decreases expression ISO RGD:735516 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 , PMID:16850161 aldehydo-D-glucosamine multiple interactions ISO RGD:735516 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 aldehydo-D-glucose multiple interactions ISO RGD:2200 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 all-trans-retinoic acid multiple interactions ISO RGD:735516 6480464 CYP26A1 protein inhibits the reaction [Tretinoin promotes the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:14592536 , PMID:15703382 all-trans-retinoic acid multiple interactions ISO RGD:2200 6480464 Mifepristone promotes the reaction [Tretinoin results in increased expression of BCL2L1 mRNA] CTD PMID:26915917 all-trans-retinoic acid increases expression ISO RGD:2200 6480464 Tretinoin results in increased expression of BCL2L1 mRNA, Tretinoin results in increased expression of BCL2L1 protein CTD PMID:26915917 all-trans-retinoic acid decreases expression ISO RGD:735516 6480464 Tretinoin results in decreased expression of BCL2L1 protein CTD PMID:14592536 more ... all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BCL2L1 mRNA CTD PMID:22498432 all-trans-retinoic acid affects expression EXP 6480464 Tretinoin affects the expression of BCL2L1 mRNA CTD PMID:16211290 all-trans-retinoic acid increases expression ISO RGD:735516 6480464 Tretinoin results in increased expression of BCL2L1 protein CTD PMID:10750663 allicin multiple interactions ISO RGD:735516 6480464 allicin inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:27561292 alloxan multiple interactions ISO RGD:2200 6480464 Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2L1 protein] CTD PMID:22138235 alloxan decreases expression ISO RGD:2200 6480464 Alloxan results in decreased expression of BCL2L1 protein CTD PMID:22138235 alpha-Zearalanol decreases expression EXP 6480464 Zeranol results in decreased expression of BCL2L1 protein CTD PMID:24120472 aluminium oxide increases expression ISO RGD:735516 6480464 Aluminum Oxide analog results in increased expression of BCL2L1 mRNA CTD PMID:23132795 alvocidib multiple interactions ISO RGD:735516 6480464 [alvocidib co-treated with Bortezomib] results in decreased expression of BCL2L1 protein more ... CTD PMID:12517783 more ... alvocidib decreases expression ISO RGD:735516 6480464 alvocidib results in decreased expression of BCL2L1 more ... CTD PMID:12517783 , PMID:16820931 amino acid multiple interactions EXP 6480464 Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2L1 protein], H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2L1 protein]] CTD PMID:25309793 ammonium chloride affects expression ISO RGD:2200 6480464 Ammonium Chloride affects the expression of BCL2L1 mRNA CTD PMID:16483693 ammonium chloride increases expression ISO RGD:2200 6480464 Ammonium Chloride results in increased expression of BCL2L1 protein CTD PMID:16483693 amosite asbestos multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Asbestos, Amosite results in increased expression of ERN1 protein], BCL2L1 protein inhibits the reaction [Asbestos, Amosite results in increased expression of XBP1 protein alternative form] CTD PMID:23885834 amphibole asbestos increases expression ISO RGD:735516 6480464 Asbestos, Amphibole results in increased expression of BCL2L1 protein CTD PMID:20855422 Anacardic acid multiple interactions ISO RGD:735516 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:18349320 anthocyanin multiple interactions ISO RGD:2200 6480464 Anthocyanins inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] CTD PMID:28856781 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:735516 6480464 pyrazolanthrone inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein] more ... CTD PMID:18281123 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:2200 6480464 pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] CTD PMID:20166895 antirheumatic drug decreases expression ISO RGD:735516 6480464 Antirheumatic Agents results in decreased expression of BCL2L1 mRNA CTD PMID:24449571 AP20187 multiple interactions ISO RGD:735516 6480464 [AP20187 results in increased activity of INSR protein mutant form] which results in decreased expression of BCL2L1 mRNA CTD PMID:29330302 apigenin decreases expression ISO RGD:2200 6480464 Apigenin results in decreased expression of BCL2L1 protein CTD PMID:24144774 apigenin multiple interactions ISO RGD:2200 6480464 Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein] CTD PMID:30152906 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] CTD PMID:30366073 arachidonic acid multiple interactions ISO RGD:735516 6480464 1 more ... CTD PMID:19540902 more ... arachidonic acid decreases expression ISO RGD:735516 6480464 Arachidonic Acid results in decreased expression of BCL2L1 protein CTD PMID:19540902 , PMID:19720122 arjunolic acid multiple interactions ISO RGD:2200 6480464 arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2L1 protein] CTD PMID:19682444 arsane increases expression ISO RGD:2200 6480464 Arsenic results in increased expression of BCL2L1 protein CTD PMID:11756236 arsane increases expression ISO RGD:735516 6480464 Arsenic results in increased expression of BCL2L1 mRNA CTD PMID:19962721 arsenic atom increases expression ISO RGD:735516 6480464 Arsenic results in increased expression of BCL2L1 mRNA CTD PMID:19962721 arsenic atom increases expression ISO RGD:2200 6480464 Arsenic results in increased expression of BCL2L1 protein CTD PMID:11756236 arsenous acid affects expression ISO RGD:735516 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23770046 arsenous acid multiple interactions ISO RGD:735516 6480464 [Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:12883035 more ... arsenous acid decreases expression ISO RGD:2200 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:19730151 more ... arsenous acid multiple interactions EXP 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein more ... CTD PMID:21078540 , PMID:28587418 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:28454374 , PMID:28587418 arsenous acid increases expression ISO RGD:735516 6480464 Arsenic Trioxide results in increased expression of BCL2L1 mRNA, Arsenic Trioxide results in increased expression of BCL2L1 protein CTD PMID:17530438 , PMID:23082001 arsenous acid decreases expression ISO RGD:735516 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:11739184 more ... arsenous acid affects expression ISO RGD:2200 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23337567 arsenous acid multiple interactions ISO RGD:2200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 , PMID:28391263 arsenous acid affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 , PMID:11468182 Atranorin decreases expression EXP 6480464 atranorin results in decreased expression of BCL2L1 protein CTD PMID:26969521 Atranorin decreases expression ISO RGD:735516 6480464 atranorin results in decreased expression of BCL2L1 protein CTD PMID:22285236 atrazine decreases expression ISO RGD:2200 6480464 Atrazine results in decreased expression of BCL2L1 mRNA, Atrazine results in decreased expression of BCL2L1 protein CTD PMID:26075868 atrazine increases expression ISO RGD:735516 6480464 Atrazine results in increased expression of BCL2L1 mRNA CTD PMID:22378314 atrazine increases expression EXP 6480464 Atrazine results in increased expression of BCL2L1 protein CTD PMID:22515965 atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 atrazine affects expression ISO RGD:2200 6480464 Atrazine affects the expression of BCL2L1 protein CTD PMID:26075868 azadirachtin A decreases expression ISO RGD:735516 6480464 azadirachtin results in decreased expression of BCL2L1 mRNA CTD PMID:20429769 azathioprine decreases expression ISO RGD:735516 6480464 Azathioprine results in decreased expression of BCL2L1 mRNA, Azathioprine results in decreased expression of BCL2L1 protein CTD PMID:12697733 azilsartan multiple interactions ISO RGD:735516 6480464 [Zinc Sulfate binds to azilsartan] which results in decreased expression of BCL2L1 protein CTD PMID:29408668 benzene multiple interactions ISO RGD:2200 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 benzo[a]pyrene decreases expression ISO RGD:735516 6480464 Benzo(a)pyrene results in decreased expression of BCL2L1 mRNA, Benzo(a)pyrene results in decreased expression of BCL2L1 protein CTD PMID:15698582 more ... benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of BCL2L1 mRNA CTD PMID:18656336 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735516 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 Benzo[a]pyrene-7,8-diol decreases expression ISO RGD:735516 6480464 benzo(a)pyrene 7, 8-dihydrodiol results in decreased expression of BCL2L1 protein CTD PMID:15698582 benzo[b]fluoranthene increases expression ISO RGD:735516 6480464 benzo(b)fluoranthene results in increased expression of BCL2L1 protein CTD PMID:21776270 benzophenanthridine decreases expression ISO RGD:735516 6480464 Benzophenanthridines analog results in decreased expression of BCL2L1 mRNA CTD PMID:23117580 benzothiazoles decreases expression ISO RGD:735516 6480464 Benzothiazoles metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:23339777 Berbamine decreases expression ISO RGD:735516 6480464 berbamine results in decreased expression of BCL2L1 protein CTD PMID:19960011 berberine decreases expression ISO RGD:735516 6480464 Berberine results in decreased expression of BCL2L1 protein CTD PMID:16505103 beta-D-glucosamine decreases expression ISO RGD:735516 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 , PMID:16850161 beta-D-glucosamine multiple interactions ISO RGD:735516 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 bicalutamide multiple interactions ISO RGD:735516 6480464 bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein], Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein] CTD PMID:28500234 bicalutamide decreases expression ISO RGD:735516 6480464 bicalutamide results in decreased expression of BCL2L1 protein CTD PMID:28500234 bilirubin IXalpha multiple interactions EXP 6480464 Bilirubin promotes the reaction [Iron-Dextran Complex results in increased expression of BCL2L1 protein] CTD PMID:20709802 biochanin A decreases expression ISO RGD:735516 6480464 biochanin A results in decreased expression of BCL2L1 protein CTD PMID:12791511 bisphenol A multiple interactions ISO RGD:735516 6480464 bisphenol A affects the reaction [Doxorubicin affects the expression of BCL2L1 mRNA], bisphenol A promotes the reaction [Doxorubicin results in increased expression of BCL2L1 protein] CTD PMID:19270784 , PMID:31470548 bisphenol A affects expression ISO RGD:735516 6480464 bisphenol A affects the expression of BCL2L1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:2200 6480464 bisphenol A results in decreased expression of BCL2L1 mRNA CTD PMID:27539358 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2L1 mRNA CTD PMID:26049153 bisphenol A affects expression ISO RGD:2200 6480464 bisphenol A affects the expression of BCL2L1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:735516 6480464 bisphenol A results in increased expression of BCL2L1 mRNA, bisphenol A results in increased expression of BCL2L1 protein CTD PMID:19270784 more ... bortezomib multiple interactions ISO RGD:735516 6480464 [alvocidib co-treated with Bortezomib] results in decreased expression of BCL2L1 protein more ... CTD PMID:15039284 more ... bortezomib decreases expression ISO RGD:735516 6480464 Bortezomib results in decreased expression of BCL2L1 mRNA, Bortezomib results in decreased expression of BCL2L1 protein CTD PMID:15543232 more ... bortezomib increases expression ISO RGD:735516 6480464 Bortezomib results in increased expression of BCL2L1 protein CTD PMID:17326159 bortezomib increases cleavage ISO RGD:735516 6480464 Bortezomib results in increased cleavage of BCL2L1 protein CTD PMID:16118318 bortezomib decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Bortezomib CTD PMID:15781649 , PMID:19100720 brassinin decreases expression ISO RGD:735516 6480464 brassinin analog results in decreased expression of BCL2L1 mRNA CTD PMID:24747292 brassinolide decreases expression ISO RGD:735516 6480464 brassinolide results in decreased expression of BCL2L1 protein CTD PMID:20833159 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of BCL2L1 mRNA CTD PMID:29038090 butein decreases expression EXP 6480464 butein results in decreased expression of BCL2L1 protein CTD PMID:11055382 C60 fullerene decreases expression ISO RGD:2200 6480464 fullerene C60 results in decreased expression of BCL2L1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Cadmium affects the localization of DNASE2 protein] CTD PMID:22677345 cadmium atom increases expression ISO RGD:2200 6480464 Cadmium results in increased expression of BCL2L1 protein CTD PMID:25388156 cadmium atom affects expression ISO RGD:2200 6480464 Cadmium affects the expression of BCL2L1 mRNA, Cadmium affects the expression of BCL2L1 protein CTD PMID:25388156 cadmium atom increases cleavage ISO RGD:735516 6480464 Cadmium results in increased cleavage of BCL2L1 protein CTD PMID:10970901 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BCL2L1 mRNA, Cadmium Chloride results in decreased expression of BCL2L1 protein CTD PMID:15501611 , PMID:21337715 cadmium dichloride increases expression ISO RGD:735516 6480464 Cadmium Chloride results in increased expression of BCL2L1 mRNA CTD PMID:27510461 cadmium dichloride multiple interactions EXP 6480464 pifithrin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2L1 protein] more ... CTD PMID:19887573 , PMID:21337715 cafestol decreases expression ISO RGD:735516 6480464 cafestol results in decreased expression of BCL2L1 protein CTD PMID:21334318 Calcimycin decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:10970895 calciol multiple interactions ISO RGD:735516 6480464 [Cholecalciferol results in increased phosphorylation of BAD protein] inhibits the reaction [BAD protein binds to BCL2L1 protein] more ... CTD PMID:18628207 calciol increases expression ISO RGD:735516 6480464 Cholecalciferol results in increased expression of BCL2L1 protein CTD PMID:18628207 calcitriol increases expression ISO RGD:2200 6480464 Calcitriol results in increased expression of BCL2L1 protein CTD PMID:17570329 calcitriol decreases expression ISO RGD:735516 6480464 Calcitriol results in decreased expression of BCL2L1 protein CTD PMID:10614618 , PMID:12479363 calyculin a multiple interactions ISO RGD:735516 6480464 calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form], calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:18348186 camalexin decreases expression ISO RGD:735516 6480464 camalexin metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:23339777 camptothecin decreases response to substance ISO RGD:735516 6480464 BCL2L1 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 camptothecin multiple interactions ISO RGD:2200 6480464 Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form] more ... CTD PMID:19339209 , PMID:19497415 camptothecin increases expression ISO RGD:2200 6480464 Camptothecin results in increased expression of BCL2L1 protein CTD PMID:19497415 camptothecin decreases expression ISO RGD:2200 6480464 Camptothecin results in decreased expression of BCL2L1 protein alternative form CTD PMID:19339209 camptothecin decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Camptothecin CTD PMID:10970895 Candesartan cilexetil increases expression ISO RGD:2200 6480464 candesartan cilexetil results in increased expression of BCL2L1 protein CTD PMID:22120037 capsaicin increases expression ISO RGD:735516 6480464 Capsaicin results in increased expression of BCL2L1 mRNA CTD PMID:19502594 capsaicin decreases expression ISO RGD:735516 6480464 Capsaicin results in decreased expression of BCL2L1 protein CTD PMID:17505005 carbamazepine affects expression ISO RGD:735516 6480464 Carbamazepine affects the expression of BCL2L1 mRNA CTD PMID:24752500 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon analog affects the expression of BCL2L1 mRNA CTD PMID:25554681 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of BCL2L1 mRNA CTD PMID:25554681 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO RGD:735516 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of BCL2L1 mRNA CTD PMID:16039398 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of BCL2L1 protein CTD PMID:18483861 carboplatin multiple interactions ISO RGD:2200 6480464 Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein] CTD PMID:18483861 carmustine affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Carmustine CTD PMID:15332326 carmustine decreases expression ISO RGD:2200 6480464 Carmustine results in decreased expression of BCL2L1 protein CTD PMID:19860839 carmustine multiple interactions ISO RGD:735516 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2L1 protein CTD PMID:16187019 carmustine decreases expression ISO RGD:735516 6480464 Carmustine results in decreased expression of BCL2L1 mRNA, Carmustine results in decreased expression of BCL2L1 protein CTD PMID:15332326 carvedilol increases expression ISO RGD:2200 6480464 carvedilol results in increased expression of BCL2L1 protein CTD PMID:20079142 casticin increases expression ISO RGD:735516 6480464 casticin results in increased expression of BCL2L1 mRNA CTD PMID:27862857 casticin decreases expression ISO RGD:735516 6480464 casticin results in decreased expression of BCL2L1 protein CTD PMID:27862857 , PMID:29098808 cefaloridine affects expression ISO RGD:2200 6480464 Cephaloridine affects the expression of BCL2L1 mRNA CTD PMID:18172885 celecoxib multiple interactions ISO RGD:735516 6480464 [Celecoxib co-treated with docetaxel] results in decreased expression of BCL2L1 protein more ... CTD PMID:15688368 , PMID:20104024 celecoxib increases expression ISO RGD:735516 6480464 Celecoxib results in increased expression of BCL2L1 mRNA CTD PMID:17342322 celecoxib decreases expression ISO RGD:735516 6480464 Celecoxib results in decreased expression of BCL2L1 protein CTD PMID:15688368 cetrorelix decreases expression ISO RGD:735516 6480464 cetrorelix results in decreased expression of BCL2L1 protein CTD PMID:21062912 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of BCL2L1 mRNA CTD PMID:23125180 chloroquine multiple interactions EXP 6480464 BCL2L1 mutant form promotes the reaction [Chloroquine results in increased activity of CASP3 protein] CTD PMID:11589424 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of BCL2L1 mRNA CTD PMID:21683644 chlorpyrifos multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of BCL2L1 mRNA, Chlorpyrifos results in increased expression of BCL2L1 protein CTD PMID:22515965 , PMID:27737797 choline multiple interactions ISO RGD:2200 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein, geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] CTD PMID:26695085 chromium(6+) decreases expression ISO RGD:735516 6480464 chromium hexavalent ion results in decreased expression of BCL2L1 protein CTD PMID:16166740 chromium(6+) increases expression ISO RGD:735516 6480464 chromium hexavalent ion results in increased expression of BCL2L1 protein CTD PMID:25448439 , PMID:29069462 chromium(6+) multiple interactions ISO RGD:735516 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2L1 protein], TP53 protein affects the reaction [chromium hexavalent ion results in decreased expression of BCL2L1 protein] CTD PMID:16166740 , PMID:25448439 chrysazin increases expression ISO RGD:735516 6480464 danthron results in increased expression of BCL2L1 protein CTD PMID:21126053 chrysazin decreases expression ISO RGD:735516 6480464 danthron results in decreased expression of BCL2L1 protein CTD PMID:21126053 chrysin multiple interactions ISO RGD:2200 6480464 chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA], chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:21167192 chrysin 5,7-dimethyl ether multiple interactions ISO RGD:2200 6480464 5, 7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:21554863 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of BCL2L1 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:735516 6480464 [Cisplatin co-treated with Quercetin] results in decreased expression of BCL2L1 protein more ... CTD PMID:15917659 more ... cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BCL2L1 mRNA, Cisplatin results in increased expression of BCL2L1 protein CTD PMID:19833167 , PMID:26546572 cisplatin multiple interactions ISO RGD:2200 6480464 SB 203580 promotes the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:19578154 cisplatin decreases expression ISO RGD:735516 6480464 Cisplatin results in decreased expression of BCL2L1 mRNA, Cisplatin results in decreased expression of BCL2L1 protein CTD PMID:17399942 more ... cisplatin decreases expression ISO RGD:2200 6480464 Cisplatin results in decreased expression of BCL2L1 mRNA, Cisplatin results in decreased expression of BCL2L1 protein CTD PMID:18172885 , PMID:19578154 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCL2L1 more ... CTD PMID:21593185 , PMID:26193055 cisplatin multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:19833167 more ... cisplatin increases expression ISO RGD:735516 6480464 Cisplatin results in increased expression of BCL2L1 protein CTD PMID:17619073 cisplatin increases degradation ISO RGD:735516 6480464 Cisplatin results in increased degradation of BCL2L1 protein CTD PMID:21821001 cisplatin decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Cisplatin, BCL2L1 results in decreased susceptibility to Cisplatin CTD PMID:16020667 , PMID:21849418 citric acid multiple interactions ISO RGD:735516 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein CTD PMID:16624386 Clivoline decreases expression ISO RGD:735516 6480464 clivorine results in decreased expression of BCL2L1 protein CTD PMID:19437449 Clivoline multiple interactions ISO RGD:735516 6480464 EGF protein inhibits the reaction [clivorine results in decreased expression of BCL2L1 protein] CTD PMID:19437449 clofarabine multiple interactions ISO RGD:735516 6480464 [clofarabine co-treated with resveratrol] inhibits the reaction [BCL2L1 mutant form results in increased expression of MCL1 protein] more ... CTD PMID:25408576 clofibrate multiple interactions EXP 6480464 Clofibrate inhibits the reaction [[Fatty Acids, Nonesterified binds to ALB protein] which results in decreased expression of BCL2L1 protein] CTD PMID:21338618 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of BCL2L1 protein CTD PMID:21338618 clonidine increases expression ISO RGD:2200 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 clonidine (amino form) increases expression ISO RGD:2200 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 clonidine (imino form) increases expression ISO RGD:2200 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 cobalt dichloride decreases expression ISO RGD:2200 6480464 cobaltous chloride results in decreased expression of BCL2L1 mRNA CTD PMID:18442013 cobalt dichloride multiple interactions ISO RGD:2200 6480464 scutellarin inhibits the reaction [cobaltous chloride results in decreased expression of BCL2L1 mRNA] CTD PMID:18442013 cocaine increases expression ISO RGD:2200 6480464 Cocaine results in increased expression of BCL2L1 mRNA, Cocaine results in increased expression of BCL2L1 mRNA alternative form CTD PMID:16076954 cocaine multiple interactions EXP 6480464 IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein] more ... CTD PMID:29673861 , PMID:30393195 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of BCL2L1 protein CTD PMID:29673861 , PMID:30393195 coenzyme Q10 multiple interactions ISO RGD:2200 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:27087047 copper atom multiple interactions ISO RGD:2200 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein, Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 copper atom decreases expression EXP 6480464 Copper analog results in decreased expression of BCL2L1 protein CTD PMID:21319953 copper(0) multiple interactions ISO RGD:2200 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein, Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 copper(0) decreases expression EXP 6480464 Copper analog results in decreased expression of BCL2L1 protein CTD PMID:21319953 copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of BCL2L1 protein CTD PMID:23313662 , PMID:24170445 cordycepin decreases expression ISO RGD:735516 6480464 cordycepin results in decreased expression of BCL2L1 protein CTD PMID:21310227 cordycepin multiple interactions ISO RGD:735516 6480464 Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2L1 protein] CTD PMID:21310227 corticosterone multiple interactions ISO RGD:2200 6480464 [Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:15755911 more ... corticosterone increases expression ISO RGD:2200 6480464 Corticosterone results in increased expression of BCL2L1 mRNA, Corticosterone results in increased expression of BCL2L1 protein CTD PMID:15755911 more ... crocidolite asbestos increases expression ISO RGD:2200 6480464 Asbestos, Crocidolite results in increased expression of BCL2L1 mRNA CTD PMID:12909582 crocidolite asbestos affects expression ISO RGD:735516 6480464 Asbestos, Crocidolite affects the expression of BCL2L1 mRNA CTD PMID:17331233 cucurbitacin E decreases expression ISO RGD:735516 6480464 cucurbitacin E results in decreased expression of BCL2L1 protein CTD PMID:27106530 curcumin multiple interactions ISO RGD:735516 6480464 [Curcumin co-treated with Doxorubicin] affects the expression of BCL2L1 mRNA more ... CTD PMID:15911101 more ... curcumin decreases expression ISO RGD:735516 6480464 Curcumin analog results in decreased expression of BCL2L1 mRNA more ... CTD PMID:12497104 more ... curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of BCL2L1 protein CTD PMID:18829502 curcumin multiple interactions ISO RGD:2200 6480464 Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] CTD PMID:15569404 curcumin multiple interactions EXP 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2L1 protein CTD PMID:17440100 curcumin increases expression ISO RGD:735516 6480464 Curcumin results in increased expression of BCL2L1 mRNA CTD PMID:15911101 cycloheximide increases expression ISO RGD:735516 6480464 Cycloheximide results in increased expression of BCL2L1 protein alternative form CTD PMID:9326359 cycloheximide multiple interactions ISO RGD:735516 6480464 Dexamethasone inhibits the reaction [Cycloheximide results in increased expression of BCL2L1 protein] CTD PMID:9326359 cyclophosphamide increases expression ISO RGD:2200 6480464 Cyclophosphamide results in increased expression of BCL2L1 mRNA CTD PMID:11599041 cyclosporin A affects expression ISO RGD:735516 6480464 Cyclosporine affects the expression of BCL2L1 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:735516 6480464 Cyclosporine results in increased expression of BCL2L1 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:735516 6480464 Cyclosporine results in decreased expression of BCL2L1 mRNA CTD PMID:21632981 cylindrospermopsin increases expression ISO RGD:735516 6480464 cylindrospermopsin results in increased expression of BCL2L1 mRNA CTD PMID:23726867 , PMID:24921660 cypermethrin decreases expression ISO RGD:2200 6480464 cypermethrin results in decreased expression of BCL2L1 protein CTD PMID:22048644 cypermethrin increases expression ISO RGD:735516 6480464 cypermethrin results in increased expression of BCL2L1 mRNA CTD PMID:27704156 cypermethrin multiple interactions ISO RGD:2200 6480464 HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein] CTD PMID:22048644 cytarabine multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein], BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein] CTD PMID:8840993 D-glucose multiple interactions ISO RGD:2200 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 dactolisib affects expression ISO RGD:735516 6480464 dactolisib affects the expression of BCL2L1 protein CTD PMID:25640480 daidzein decreases expression ISO RGD:735516 6480464 daidzein results in decreased expression of BCL2L1 protein CTD PMID:12791511 Deguelin decreases expression ISO RGD:735516 6480464 deguelin results in decreased expression of BCL2L1 mRNA, deguelin results in decreased expression of BCL2L1 protein CTD PMID:19365708 more ... Deguelin multiple interactions ISO RGD:735516 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of BCL2L1 mRNA] CTD PMID:22623043 dehydroepiandrosterone increases expression ISO RGD:2200 6480464 Dehydroepiandrosterone results in increased expression of BCL2L1 protein CTD PMID:16407456 dehydroepiandrosterone multiple interactions ISO RGD:2200 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2L1 protein] more ... CTD PMID:16407456 dehydroepiandrosterone sulfate increases expression ISO RGD:2200 6480464 Dehydroepiandrosterone Sulfate results in increased expression of BCL2L1 protein CTD PMID:16407456 dehydroepiandrosterone sulfate multiple interactions ISO RGD:2200 6480464 Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2L1 protein] CTD PMID:16407456 demethoxyfumitremorgin C decreases expression ISO RGD:735516 6480464 demethoxyfumitremorgin C results in decreased expression of BCL2L1 protein CTD PMID:28359723 deoxynivalenol decreases expression ISO RGD:735516 6480464 deoxynivalenol results in decreased expression of BCL2L1 mRNA CTD PMID:22846391 depsipeptide multiple interactions ISO RGD:735516 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of BCL2L1 mRNA CTD PMID:17064661 dexamethasone multiple interactions ISO RGD:735516 6480464 Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 mRNA] more ... CTD PMID:21940343 , PMID:9326359 dexamethasone decreases expression ISO RGD:2200 6480464 Dexamethasone results in decreased expression of BCL2L1 protein CTD PMID:30506661 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA CTD PMID:22733784 dexamethasone decreases expression ISO RGD:735516 6480464 Dexamethasone results in decreased expression of BCL2L1 protein CTD PMID:15804364 , PMID:19428934 dexamethasone increases expression ISO RGD:735516 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA alternative form, Dexamethasone results in increased expression of BCL2L1 protein alternative form CTD PMID:11319611 , PMID:17070682 dexamethasone increases expression ISO RGD:2200 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA alternative form more ... CTD PMID:10200566 more ... dexamethasone multiple interactions EXP 6480464 2 more ... CTD PMID:15987750 , PMID:29704545 dexamethasone multiple interactions ISO RGD:2200 6480464 Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form] more ... CTD PMID:16407456 more ... dexamethasone increases stability ISO RGD:735516 6480464 Dexamethasone results in increased stability of BCL2L1 mRNA CTD PMID:9326359 dexmedetomidine multiple interactions ISO RGD:2200 6480464 atipamezole inhibits the reaction [Dexmedetomidine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of BCL2L1 protein]], Dexmedetomidine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of BCL2L1 protein] CTD PMID:30597158 dextromethorphan multiple interactions ISO RGD:2200 6480464 Dizocilpine Maleate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein], traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein] CTD PMID:28916251 dextromethorphan decreases expression ISO RGD:2200 6480464 Dextromethorphan results in decreased expression of BCL2L1 protein CTD PMID:28916251 diallyl trisulfide decreases expression ISO RGD:735516 6480464 diallyl trisulfide results in decreased expression of BCL2L1 protein CTD PMID:17513609 , PMID:20055834 diarsenic trioxide affects expression ISO RGD:735516 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23770046 diarsenic trioxide affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 , PMID:11468182 diarsenic trioxide affects expression ISO RGD:2200 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23337567 diarsenic trioxide decreases expression ISO RGD:735516 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:11739184 more ... diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:28454374 , PMID:28587418 diarsenic trioxide multiple interactions EXP 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein more ... CTD PMID:21078540 , PMID:28587418 diarsenic trioxide decreases expression ISO RGD:2200 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA, Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:19730151 more ... diarsenic trioxide multiple interactions ISO RGD:2200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 , PMID:28391263 diarsenic trioxide multiple interactions ISO RGD:735516 6480464 [Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:12883035 more ... diarsenic trioxide increases expression ISO RGD:735516 6480464 Arsenic Trioxide results in increased expression of BCL2L1 mRNA, Arsenic Trioxide results in increased expression of BCL2L1 protein CTD PMID:17530438 , PMID:23082001 diazinon affects expression ISO RGD:2200 6480464 Diazinon affects the expression of BCL2L1 mRNA CTD PMID:22546817 diazoxide multiple interactions ISO RGD:735516 6480464 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 mRNA alternative form], 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 protein alternative form] CTD PMID:15326191 diazoxide increases expression ISO RGD:735516 6480464 Diazoxide results in increased expression of BCL2L1 mRNA alternative form, Diazoxide results in increased expression of BCL2L1 protein alternative form CTD PMID:15326191 dibenz[a,h]anthracene decreases expression ISO RGD:735516 6480464 1 more ... CTD PMID:16269432 dibenzo[a,l]pyrene decreases expression ISO RGD:735516 6480464 dibenzo(a, l)pyrene results in decreased expression of BCL2L1 mRNA CTD PMID:16269432 diclofenac increases expression ISO RGD:735516 6480464 Diclofenac results in increased expression of BCL2L1 mRNA alternative form CTD PMID:14609740 diclofenac affects expression ISO RGD:735516 6480464 Diclofenac affects the expression of BCL2L1 mRNA CTD PMID:24752500 dieldrin affects expression ISO RGD:2200 6480464 Dieldrin affects the expression of BCL2L1 mRNA CTD PMID:22546817 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of BCL2L1 mRNA CTD PMID:15545218 dimethylarsinic acid increases expression ISO RGD:735516 6480464 Cacodylic Acid results in increased expression of BCL2L1 mRNA CTD PMID:17720352 dioscin decreases expression ISO RGD:735516 6480464 dioscin results in decreased expression of BCL2L1 mRNA, dioscin results in decreased expression of BCL2L1 protein CTD PMID:22334414 , PMID:29990575 diosgenin multiple interactions ISO RGD:735516 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:16331273 diosgenin decreases expression ISO RGD:735516 6480464 Diosgenin results in decreased expression of BCL2L1 protein CTD PMID:16331273 dioxygen decreases expression ISO RGD:2200 6480464 Oxygen deficiency results in decreased expression of BCL2L1 mRNA, Oxygen deficiency results in decreased expression of BCL2L1 protein CTD PMID:11042672 dioxygen multiple interactions ISO RGD:735516 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO RGD:735516 6480464 Oxygen deficiency results in increased expression of BCL2L1 mRNA CTD PMID:23452621 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL2L1 mRNA, Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA] CTD PMID:22629407 , PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of BCL2L1 mRNA CTD PMID:22629407 dioxygen multiple interactions ISO RGD:2200 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:11042672 , PMID:21124846 dipyridamole multiple interactions ISO RGD:735516 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 mRNA], Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 protein] CTD PMID:20063052 dorsomorphin multiple interactions ISO RGD:735516 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL2L1 mRNA CTD PMID:27188386 dorsomorphin multiple interactions EXP 6480464 [dorsomorphin inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein]] which results in increased activity of CASP3 protein, dorsomorphin inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein] CTD PMID:20709802 doxorubicin increases expression ISO RGD:735516 6480464 Doxorubicin results in increased expression of BCL2L1 mRNA, Doxorubicin results in increased expression of BCL2L1 protein CTD PMID:15939500 more ... doxorubicin affects expression ISO RGD:735516 6480464 Doxorubicin affects the expression of BCL2L1 mRNA CTD PMID:31470548 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCL2L1 mRNA CTD PMID:15485691 more ... doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:17673183 , PMID:20144634 doxorubicin decreases expression ISO RGD:735516 6480464 Doxorubicin results in decreased expression of BCL2L1 mRNA, Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:16843435 more ... doxorubicin decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Doxorubicin CTD PMID:11468182 , PMID:15781649 doxorubicin affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Doxorubicin CTD PMID:17923112 doxorubicin decreases ubiquitination ISO RGD:2200 6480464 Doxorubicin results in decreased ubiquitination of BCL2L1 protein CTD PMID:12967636 doxorubicin decreases expression ISO RGD:2200 6480464 Doxorubicin results in decreased expression of BCL2L1 mRNA, Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:14736733 more ... doxorubicin multiple interactions ISO RGD:2200 6480464 [Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:15755911 more ... doxorubicin multiple interactions EXP 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein], Silymarin inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:17673183 , PMID:20144634 doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of BCL2L1 mRNA CTD PMID:16439991 doxorubicin decreases response to substance EXP 6480464 BCL2L1 protein results in decreased susceptibility to Doxorubicin CTD PMID:16439991 doxorubicin multiple interactions ISO RGD:735516 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:15289866 more ... doxycycline multiple interactions EXP 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:17673183 elemental selenium increases expression ISO RGD:735516 6480464 Selenium results in increased expression of BCL2L1 mRNA CTD PMID:19244175 elemental selenium multiple interactions ISO RGD:2200 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCL2L1 protein CTD PMID:22515965 endosulfan increases expression ISO RGD:2200 6480464 Endosulfan results in increased expression of BCL2L1 mRNA CTD PMID:29391264 endosulfan multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 entinostat decreases expression EXP 6480464 entinostat results in decreased expression of BCL2L1 protein CTD PMID:21041383 erdosteine multiple interactions EXP 6480464 erdosteine inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 mRNA], erdosteine inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:26193055 esculetin multiple interactions ISO RGD:735516 6480464 [esculetin co-treated with Paclitaxel] results in decreased expression of BCL2L1 protein CTD PMID:16051289 esculetin decreases expression ISO RGD:735516 6480464 esculetin results in decreased expression of BCL2L1 protein CTD PMID:26388407 etacrynic acid multiple interactions ISO RGD:735516 6480464 [arsenic trioxide co-treated with Ethacrynic Acid] results in increased expression of BCL2L1 protein CTD PMID:23082001 etacrynic acid increases expression ISO RGD:735516 6480464 Ethacrynic Acid results in increased expression of BCL2L1 protein CTD PMID:23082001 ethanol multiple interactions ISO RGD:2200 6480464 Ethanol promotes the reaction [BAX protein binds to BCL2L1 protein], salvianolic acid B inhibits the reaction [Ethanol results in decreased expression of BCL2L1 protein] CTD PMID:16035105 , PMID:24769256 ethanol decreases expression ISO RGD:2200 6480464 Ethanol results in decreased expression of BCL2L1 mRNA, Ethanol results in decreased expression of BCL2L1 protein CTD PMID:16098508 , PMID:24769256 ethanol affects localization ISO RGD:2200 6480464 Ethanol affects the localization of BCL2L1 protein CTD PMID:16035105 etoposide multiple interactions ISO RGD:735516 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] more ... CTD PMID:10620629 more ... etoposide affects expression ISO RGD:735516 6480464 Etoposide affects the expression of BCL2L1 protein CTD PMID:15215046 etoposide decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Etoposide CTD PMID:11468182 eugenol multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] CTD PMID:20434464 Evodiamine multiple interactions ISO RGD:735516 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:15710601 fenofibrate decreases expression ISO RGD:735516 6480464 Fenofibrate results in decreased expression of BCL2L1 mRNA CTD PMID:20520642 finasteride multiple interactions ISO RGD:2200 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 flavonoids decreases expression ISO RGD:2200 6480464 Flavonoids results in decreased expression of BCL2L1 mRNA CTD PMID:18035473 flavonoids decreases expression ISO RGD:735516 6480464 Flavonoids results in decreased expression of BCL2L1 mRNA, Flavonoids results in decreased expression of BCL2L1 protein CTD PMID:24036141 fluoxetine increases expression ISO RGD:2200 6480464 Fluoxetine results in increased expression of BCL2L1 mRNA, Fluoxetine results in increased expression of BCL2L1 protein CTD PMID:21852994 fluoxetine decreases expression ISO RGD:2200 6480464 Fluoxetine results in decreased expression of BCL2L1 protein CTD PMID:19298536 fluoxetine affects expression ISO RGD:2200 6480464 Fluoxetine affects the expression of BCL2L1 mRNA CTD PMID:21740920 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of BCL2L1 mRNA CTD PMID:19442681 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of BCL2L1 protein CTD PMID:16595132 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with MAPT protein mutant form] results in decreased expression of BCL2L1 protein], TNF protein affects the reaction [Folic Acid results in decreased expression of BCL2L1 protein] CTD PMID:16595132 , PMID:29068127 fucoxanthin multiple interactions ISO RGD:735516 6480464 Acetylcysteine inhibits the reaction [fucoxanthin results in decreased expression of BCL2L1 protein] CTD PMID:20594983 fucoxanthin decreases expression ISO RGD:735516 6480464 fucoxanthin results in decreased expression of BCL2L1 protein CTD PMID:20594983 fulvestrant multiple interactions ISO RGD:2200 6480464 fulvestrant inhibits the reaction [dan-shen root extract inhibits the reaction [IGF2 protein mutant form results in increased expression of BCL2L1 protein]] CTD PMID:23419388 furan increases methylation ISO RGD:2200 6480464 furan results in increased methylation of BCL2L1 gene CTD PMID:22079235 furan increases expression ISO RGD:2200 6480464 furan results in increased expression of BCL2L1 mRNA CTD PMID:25539665 Fusarenone X increases expression EXP 6480464 fusarenon-X results in increased expression of BCL2L1 mRNA CTD PMID:24983900 galangin decreases expression ISO RGD:735516 6480464 galangin results in decreased expression of BCL2L1 protein CTD PMID:25450235 gamma-aminobutyric acid increases expression ISO RGD:2200 6480464 gamma-Aminobutyric Acid results in increased expression of BCL2L1 protein CTD PMID:29708300 gamma-hexachlorocyclohexane multiple interactions ISO RGD:2200 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein], TEMPO inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 gamma-hexachlorocyclohexane increases expression ISO RGD:2200 6480464 Hexachlorocyclohexane results in increased expression of BCL2L1 protein CTD PMID:19041923 , PMID:22001173 gamma-tocopherol decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 Gastrodin increases expression EXP 6480464 gastrodin results in increased expression of BCL2L1 mRNA CTD PMID:23578476 geldanamycin decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to geldanamycin CTD PMID:15781649 geldanamycin multiple interactions ISO RGD:735516 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2L1 protein CTD PMID:15781649 gemcitabine decreases expression ISO RGD:735516 6480464 gemcitabine results in decreased expression of BCL2L1 protein CTD PMID:15476743 gemcitabine multiple interactions ISO RGD:735516 6480464 gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 mRNA], gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 protein] CTD PMID:16929163 gemcitabine multiple interactions EXP 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2L1 protein CTD PMID:17440100 genistein multiple interactions ISO RGD:735516 6480464 [Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2L1 protein, Genistein promotes the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:18546268 , PMID:21078540 genistein decreases expression ISO RGD:735516 6480464 Genistein results in decreased expression of BCL2L1 protein CTD PMID:12791511 more ... genistein decreases expression EXP 6480464 Genistein results in decreased expression of BCL2L1 mRNA, Genistein results in decreased expression of BCL2L1 protein CTD PMID:21048042 , PMID:21078540 genistein multiple interactions EXP 6480464 [Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2L1 protein CTD PMID:21078540 gentamycin decreases expression ISO RGD:2200 6480464 Gentamicins results in decreased expression of BCL2L1 protein CTD PMID:17132701 , PMID:19491382 gentamycin decreases expression ISO RGD:735516 6480464 Gentamicins results in decreased expression of BCL2L1 mRNA CTD PMID:29992668 gentamycin multiple interactions ISO RGD:2200 6480464 Carnitine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] more ... CTD PMID:17132701 more ... geraniol multiple interactions ISO RGD:2200 6480464 geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] CTD PMID:26695085 glucose multiple interactions ISO RGD:2200 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 glutathione multiple interactions ISO RGD:735516 6480464 Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]] CTD PMID:17640567 glyphosate increases expression ISO RGD:735516 6480464 glyphosate results in increased expression of BCL2L1 mRNA CTD PMID:17984146 gold atom multiple interactions ISO RGD:735516 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:735516 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA CTD PMID:28433809 gossypol multiple interactions ISO RGD:735516 6480464 Gossypol analog binds to and affects the activity of BCL2L1 protein CTD PMID:16020667 gossypol decreases expression ISO RGD:735516 6480464 Gossypol results in decreased expression of BCL2L1 protein CTD PMID:18840529 GW 6471 multiple interactions EXP 6480464 GW 6471 inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein] CTD PMID:20709802 Gyrophoric acid decreases expression ISO RGD:735516 6480464 gyrophoric acid results in decreased expression of BCL2L1 protein CTD PMID:22285236 haloperidol multiple interactions ISO RGD:2200 6480464 EPO protein inhibits the reaction [Haloperidol results in decreased expression of BCL2L1 protein] CTD PMID:17805306 haloperidol increases expression ISO RGD:2200 6480464 Haloperidol results in increased expression of BCL2L1 protein CTD PMID:16462815 haloperidol decreases expression ISO RGD:2200 6480464 Haloperidol results in decreased expression of BCL2L1 protein CTD PMID:17805306 hyaluronic acid multiple interactions ISO RGD:735516 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 hydrogen peroxide multiple interactions ISO RGD:2200 6480464 GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]] more ... CTD PMID:14505808 , PMID:25726415 hydrogen peroxide decreases expression ISO RGD:735516 6480464 Hydrogen Peroxide results in decreased expression of BCL2L1 protein CTD PMID:15703382 , PMID:22269385 hydrogen peroxide multiple interactions ISO RGD:735516 6480464 CYP26A1 protein inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein] more ... CTD PMID:15142122 , PMID:15703382 hydrogen peroxide affects expression ISO RGD:735516 6480464 Hydrogen Peroxide affects the expression of BCL2L1 protein CTD PMID:21179406 hydrogen peroxide decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Hydrogen Peroxide CTD PMID:10970895 hydrogen peroxide increases expression ISO RGD:2200 6480464 Hydrogen Peroxide results in increased expression of BCL2L1 mRNA CTD PMID:14689451 hydrogen peroxide decreases expression ISO RGD:2200 6480464 Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA, Hydrogen Peroxide results in decreased expression of BCL2L1 protein CTD PMID:14505808 , PMID:25726415 hydroxamic acid decreases expression ISO RGD:735516 6480464 Hydroxamic Acids analog results in decreased expression of BCL2L1 protein CTD PMID:26088127 hydroxyurea decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Hydroxyurea CTD PMID:10970895 ibrutinib decreases expression ISO RGD:735516 6480464 PCI 32765 results in decreased expression of BCL2L1 mRNA CTD PMID:26254443 ibuprofen multiple interactions ISO RGD:735516 6480464 [Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form more ... CTD PMID:18348186 Ilimaquinone decreases expression ISO RGD:735516 6480464 ilimaquinone results in decreased expression of BCL2L1 protein CTD PMID:24930757 indirubin-3'-monoxime multiple interactions ISO RGD:735516 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA CTD PMID:18958680 indole-3-methanol decreases expression ISO RGD:735516 6480464 indole-3-carbinol results in decreased expression of BCL2L1 CTD PMID:16082211 indometacin decreases expression ISO RGD:2200 6480464 Indomethacin results in decreased expression of BCL2L1 mRNA, Indomethacin results in decreased expression of BCL2L1 protein CTD PMID:18375387 , PMID:19220725 indometacin decreases expression ISO RGD:735516 6480464 Indomethacin results in decreased expression of BCL2L1 protein CTD PMID:11062132 , PMID:16572323 indometacin multiple interactions ISO RGD:2200 6480464 Lansoprazole inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 protein], Melatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 mRNA] CTD PMID:18375387 , PMID:19220725 irinotecan decreases expression ISO RGD:735516 6480464 Irinotecan results in decreased expression of BCL2L1 mRNA CTD PMID:16432164 irinotecan multiple interactions ISO RGD:735516 6480464 Irinotecan promotes the reaction [AS602868 results in decreased expression of BCL2L1 mRNA] CTD PMID:18182997 iron atom multiple interactions ISO RGD:735516 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein more ... CTD PMID:19620254 more ... iron dextran multiple interactions EXP 6480464 [ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein] more ... CTD PMID:20709802 iron dextran increases expression EXP 6480464 Iron-Dextran Complex results in increased expression of BCL2L1 protein CTD PMID:20709802 iron(0) multiple interactions ISO RGD:735516 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein more ... CTD PMID:19620254 more ... isoflavones multiple interactions ISO RGD:735516 6480464 [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2L1 protein CTD PMID:18640131 isoflurane affects expression ISO RGD:2200 6480464 Isoflurane affects the expression of BCL2L1 protein CTD PMID:25597859 isoliquiritigenin decreases expression ISO RGD:735516 6480464 isoliquiritigenin results in decreased expression of BCL2L1 protein CTD PMID:15729620 isoliquiritigenin decreases expression EXP 6480464 isoliquiritigenin results in decreased expression of BCL2L1 protein CTD PMID:11055382 isoliquiritigenin decreases phosphorylation ISO RGD:735516 6480464 isoliquiritigenin results in decreased phosphorylation of BCL2L1 protein CTD PMID:23747687 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCL2L1 mRNA CTD PMID:20003209 isoprenaline decreases expression ISO RGD:735516 6480464 Isoproterenol results in decreased expression of BCL2L1 mRNA CTD PMID:24286936 isoprenaline decreases expression ISO RGD:2200 6480464 Isoproterenol results in decreased expression of BCL2L1 mRNA, Isoproterenol results in decreased expression of BCL2L1 protein CTD PMID:24286936 more ... isoprenaline increases expression ISO RGD:2200 6480464 Isoproterenol results in increased expression of BCL2L1 mRNA alternative form more ... CTD PMID:12738230 , PMID:16116328 isoprenaline multiple interactions ISO RGD:2200 6480464 Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein] more ... CTD PMID:12738230 more ... isorhamnetin decreases expression ISO RGD:735516 6480464 3-methylquercetin results in decreased expression of BCL2L1 mRNA, 3-methylquercetin results in decreased expression of BCL2L1 protein CTD PMID:22992727 isotretinoin increases expression ISO RGD:735516 6480464 Isotretinoin results in increased expression of BCL2L1 mRNA, Isotretinoin results in increased expression of BCL2L1 protein CTD PMID:21159604 isotretinoin decreases expression ISO RGD:735516 6480464 Isotretinoin results in decreased expression of BCL2L1 protein CTD PMID:16135400 kaempferol multiple interactions ISO RGD:735516 6480464 kaempferol promotes the reaction [BBC3 protein binds to BCL2L1 protein], TP53 protein affects the reaction [kaempferol promotes the reaction [BBC3 protein binds to BCL2L1 protein]] CTD PMID:19028473 kurarinol multiple interactions ISO RGD:735516 6480464 kurarinol inhibits the reaction [STAT3 protein binds to BCL2L1 promoter] CTD PMID:24997323 kurarinol multiple interactions EXP 6480464 kurarinol inhibits the reaction [STAT3 protein binds to BCL2L1 promoter] CTD PMID:24997323 kurarinol decreases expression ISO RGD:735516 6480464 kurarinol results in decreased expression of BCL2L1 mRNA, kurarinol results in decreased expression of BCL2L1 protein CTD PMID:24997323 kurarinol decreases expression EXP 6480464 kurarinol results in decreased expression of BCL2L1 mRNA, kurarinol results in decreased expression of BCL2L1 protein CTD PMID:24997323 L-ascorbic acid multiple interactions ISO RGD:2200 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2L1 protein], Ascorbic Acid inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] CTD PMID:18758938 , PMID:21262251 L-methionine multiple interactions ISO RGD:2200 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein, geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] CTD PMID:26695085 lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:15673306 lansoprazole multiple interactions ISO RGD:2200 6480464 Lansoprazole inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 protein] CTD PMID:18375387 lead diacetate affects expression ISO RGD:735516 6480464 lead acetate affects the expression of BCL2L1 protein CTD PMID:26542248 lead diacetate multiple interactions ISO RGD:735516 6480464 HMOX1 protein affects the reaction [lead acetate affects the expression of BCL2L1 protein] CTD PMID:26542248 lead(0) multiple interactions ISO RGD:2200 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Lead results in decreased expression of BCL2L1 protein] CTD PMID:29630945 lead(0) decreases expression ISO RGD:2200 6480464 Lead results in decreased expression of BCL2L1 protein CTD PMID:29630945 lead(2+) decreases expression ISO RGD:2200 6480464 Lead results in decreased expression of BCL2L1 protein CTD PMID:29630945 lead(2+) multiple interactions ISO RGD:2200 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Lead results in decreased expression of BCL2L1 protein] CTD PMID:29630945 leptomycin B multiple interactions ISO RGD:735516 6480464 leptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2L1 protein] CTD PMID:14592536 linalool decreases expression ISO RGD:735516 6480464 linalool results in decreased expression of BCL2L1 mRNA CTD PMID:28567457 lipoic acid multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 lipopolysaccharide multiple interactions ISO RGD:735516 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 mRNA] more ... CTD PMID:18789402 , PMID:25725100 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BCL2L1 mRNA, Lipopolysaccharides results in increased expression of BCL2L1 protein CTD PMID:18789402 , PMID:23107598 lipopolysaccharide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] more ... CTD PMID:18789402 more ... lipopolysaccharide increases expression ISO RGD:735516 6480464 Lipopolysaccharides results in increased expression of BCL2L1 mRNA CTD PMID:25725100 lithium chloride increases expression ISO RGD:735516 6480464 Lithium Chloride results in increased expression of BCL2L1 mRNA, Lithium Chloride results in increased expression of BCL2L1 protein CTD PMID:19101580 , PMID:22493441 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of BCL2L1 mRNA CTD PMID:19433268 lithocholic acid multiple interactions EXP 6480464 1 more ... CTD PMID:19433268 lonafarnib multiple interactions ISO RGD:735516 6480464 lonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2L1 protein] CTD PMID:16118318 lonidamine decreases expression ISO RGD:735516 6480464 lonidamine results in decreased expression of BCL2L1 protein CTD PMID:21889928 lovastatin decreases expression ISO RGD:2200 6480464 Lovastatin results in decreased expression of BCL2L1 protein CTD PMID:11178870 lovastatin multiple interactions ISO RGD:2200 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2L1 protein] CTD PMID:11178870 LSM-2726 multiple interactions ISO RGD:2200 6480464 Dizocilpine Maleate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein], traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein] CTD PMID:28916251 LSM-2726 decreases expression ISO RGD:2200 6480464 Dextromethorphan results in decreased expression of BCL2L1 protein CTD PMID:28916251 lutein increases expression ISO RGD:735516 6480464 Lutein results in increased expression of BCL2L1 protein CTD PMID:10750663 luteolin decreases expression ISO RGD:735516 6480464 Luteolin results in decreased expression of BCL2L1 protein CTD PMID:21601631 luteolin multiple interactions ISO RGD:735516 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2L1 protein] CTD PMID:25448439 LY294002 multiple interactions ISO RGD:2200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein]] CTD PMID:23201927 LY294002 decreases expression ISO RGD:735516 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BCL2L1 protein CTD PMID:14762343 , PMID:21173233 LY294002 increases degradation ISO RGD:735516 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of BCL2L1 protein CTD PMID:21821001 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]] CTD PMID:18789402 , PMID:25895139 LY294002 multiple interactions ISO RGD:735516 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] more ... CTD PMID:18789402 more ... maneb multiple interactions ISO RGD:735516 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BCL2L1 protein CTD PMID:15824117 maneb increases expression ISO RGD:735516 6480464 Maneb results in increased expression of BCL2L1 mRNA CTD PMID:18266926 manganese atom multiple interactions ISO RGD:2200 6480464 [Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein, PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein] CTD PMID:25791630 manganese atom decreases expression ISO RGD:2200 6480464 Manganese results in decreased expression of BCL2L1 protein CTD PMID:25791630 manganese(0) multiple interactions ISO RGD:2200 6480464 [Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein, PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein] CTD PMID:25791630 manganese(0) decreases expression ISO RGD:2200 6480464 Manganese results in decreased expression of BCL2L1 protein CTD PMID:25791630 manganese(II) chloride decreases expression ISO RGD:2200 6480464 manganese chloride results in decreased expression of BCL2L1 protein CTD PMID:27107493 mangiferin decreases expression ISO RGD:735516 6480464 mangiferin results in decreased expression of BCL2L1 protein CTD PMID:21547680 , PMID:26996543 melamine decreases expression ISO RGD:735516 6480464 melamine results in decreased expression of BCL2L1 protein CTD PMID:22915474 melatonin multiple interactions ISO RGD:2200 6480464 Melatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 mRNA] CTD PMID:19220725 melatonin multiple interactions ISO RGD:735516 6480464 Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein] CTD PMID:21244482 mercaptopurine decreases expression ISO RGD:735516 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 mercury dichloride increases expression ISO RGD:2200 6480464 Mercuric Chloride results in increased expression of BCL2L1 mRNA CTD PMID:8872981 metformin multiple interactions ISO RGD:735516 6480464 Cisplatin promotes the reaction [Metformin results in decreased expression of BCL2L1 protein] CTD PMID:21388661 metformin decreases expression ISO RGD:735516 6480464 Metformin results in decreased expression of BCL2L1 protein CTD PMID:21388661 methamphetamine affects expression ISO RGD:2200 6480464 Methamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 methamphetamine increases methylation EXP 6480464 Methamphetamine results in increased methylation of BCL2L1 promoter CTD PMID:26307267 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BCL2L1 mRNA CTD PMID:26307267 methamphetamine multiple interactions ISO RGD:735516 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 methamphetamine decreases expression ISO RGD:735516 6480464 Methamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 methotrexate increases expression ISO RGD:735516 6480464 Methotrexate results in increased expression of BCL2L1 mRNA CTD PMID:21678067 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of BCL2L1 mRNA CTD PMID:20829426 , PMID:23000595 methylmercury chloride decreases expression ISO RGD:2200 6480464 methylmercuric chloride results in decreased expression of BCL2L1 protein CTD PMID:28821999 methylmercury(1+) multiple interactions ISO RGD:2200 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 methylparaben increases expression ISO RGD:735516 6480464 methylparaben results in increased expression of BCL2L1 mRNA, methylparaben results in increased expression of BCL2L1 protein CTD PMID:24481588 metoprolol multiple interactions ISO RGD:2200 6480464 Metoprolol inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 protein] CTD PMID:12738230 mifepristone multiple interactions ISO RGD:2200 6480464 Mifepristone affects the reaction [Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]] more ... CTD PMID:15755911 more ... mitomycin C decreases expression ISO RGD:735516 6480464 Mitomycin results in decreased expression of BCL2L1 mRNA CTD PMID:18615204 mitomycin C increases expression ISO RGD:735516 6480464 Mitomycin results in increased expression of BCL2L1 protein CTD PMID:11867586 mitoxantrone multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein], BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] CTD PMID:8840993 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA], AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein] CTD PMID:18755736 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA, mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein CTD PMID:18755736 monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 morin decreases expression ISO RGD:735516 6480464 morin results in decreased expression of BCL2L1 mRNA CTD PMID:28689916 morphine decreases expression ISO RGD:2200 6480464 Morphine results in decreased expression of BCL2L1 mRNA CTD PMID:15183518 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:735516 6480464 N more ... CTD PMID:19887557 N,N-dimethylformamide increases expression ISO RGD:735516 6480464 Dimethylformamide results in increased expression of BCL2L1 protein CTD PMID:29984871 N,N-dimethylformamide multiple interactions ISO RGD:735516 6480464 Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein] CTD PMID:29984871 N,N-dimethylformamide multiple interactions ISO RGD:2200 6480464 [Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein CTD PMID:20097184 N-(6-acetamidohexyl)acetamide affects expression ISO RGD:735516 6480464 hexamethylene bisacetamide affects the expression of BCL2L1 CTD PMID:15543656 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [BAD protein binds to BCL2L1 protein] CTD PMID:12629175 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide multiple interactions EXP 6480464 N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] CTD PMID:30366073 N-acetyl-L-cysteine multiple interactions ISO RGD:735516 6480464 Acetylcysteine inhibits the reaction [[Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein] more ... CTD PMID:18281123 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:2200 6480464 Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein], Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein] CTD PMID:18483861 , PMID:22085843 N-acetylsphingosine multiple interactions ISO RGD:735516 6480464 LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein] CTD PMID:21821001 N-acetylsphingosine increases degradation ISO RGD:735516 6480464 N-acetylsphingosine results in increased degradation of BCL2L1 protein CTD PMID:21821001 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735516 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2L1 protein] CTD PMID:19540902 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:735516 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2L1 protein CTD PMID:16960866 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BCL2L1 protein] CTD PMID:19812371 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of BCL2L1 mRNA CTD PMID:30944280 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 [CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein], NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein]] CTD PMID:28268219 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:735516 6480464 Curcumin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] CTD PMID:30463061 N-methyl-4-phenylpyridinium decreases expression ISO RGD:735516 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:24810058 , PMID:30463061 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:28268219 N-methyl-4-phenylpyridinium increases expression ISO RGD:735516 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L1 mRNA CTD PMID:18266926 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:2200 6480464 ML 9 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] more ... CTD PMID:24358303 N-methyl-4-phenylpyridinium decreases expression ISO RGD:2200 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:24358303 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 N-methyl-N'-nitro-N-nitrosoguanidine increases expression EXP 6480464 Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] CTD PMID:20434464 N-nitrosodiethylamine multiple interactions ISO RGD:2200 6480464 5 more ... CTD PMID:11749691 more ... N-nitrosodiethylamine increases expression ISO RGD:2200 6480464 Diethylnitrosamine results in increased expression of BCL2L1 mRNA, Diethylnitrosamine results in increased expression of BCL2L1 protein CTD PMID:21167192 more ... N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of BCL2L1 mRNA CTD PMID:21607683 N-nitrosodimethylamine multiple interactions ISO RGD:2200 6480464 Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein], idoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] CTD PMID:14659978 N-nitrosodimethylamine decreases expression ISO RGD:2200 6480464 Dimethylnitrosamine results in decreased expression of BCL2L1 protein CTD PMID:14659978 NAD zwitterion multiple interactions EXP 6480464 NAD inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:11461765 NAD(+) multiple interactions EXP 6480464 NAD inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:11461765 nickel dichloride increases expression ISO RGD:735516 6480464 nickel chloride results in increased expression of BCL2L1 protein CTD PMID:21837363 nickel dichloride decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to nickel chloride CTD PMID:23828460 nickel dichloride affects expression ISO RGD:2200 6480464 nickel chloride affects the expression of BCL2L1 mRNA CTD PMID:22546817 nickel dichloride decreases expression ISO RGD:2200 6480464 nickel chloride results in decreased expression of BCL2L1 protein CTD PMID:20391133 nickel subsulfide decreases expression ISO RGD:735516 6480464 nickel subsulfide results in decreased expression of BCL2L1 protein CTD PMID:20112989 nickel sulfate increases expression ISO RGD:735516 6480464 nickel sulfate results in increased expression of BCL2L1 protein CTD PMID:21776270 Niclosamide decreases expression ISO RGD:735516 6480464 Niclosamide analog results in decreased expression of BCL2L1 protein, Niclosamide results in decreased expression of BCL2L1 protein CTD PMID:26116531 more ... Niclosamide multiple interactions ISO RGD:735516 6480464 [Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2L1 mRNA more ... CTD PMID:20215516 more ... nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BCL2L1 mRNA CTD PMID:22687363 nicotine multiple interactions EXP 6480464 resveratrol inhibits the reaction [Nicotine results in decreased expression of BCL2L1 mRNA] CTD PMID:22687363 nitric oxide decreases expression ISO RGD:735516 6480464 Nitric Oxide results in decreased expression of BCL2L1 protein CTD PMID:15126337 nitric oxide increases expression ISO RGD:2200 6480464 Nitric Oxide results in increased expression of BCL2L1 mRNA CTD PMID:25726415 nitric oxide multiple interactions ISO RGD:2200 6480464 GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]] more ... CTD PMID:25726415 nitrobenzenes decreases expression ISO RGD:2200 6480464 Nitrobenzenes analog results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 nitrofen decreases expression ISO RGD:735516 6480464 nitrofen results in decreased expression of BCL2L1 protein CTD PMID:17439724 nitroprusside multiple interactions ISO RGD:2200 6480464 MAPK3 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA], MAPK8 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA] CTD PMID:20132804 nitroprusside decreases expression ISO RGD:2200 6480464 Nitroprusside results in decreased expression of BCL2L1 mRNA, Nitroprusside results in decreased expression of BCL2L1 protein CTD PMID:20132804 Nodularin increases expression ISO RGD:2200 6480464 nodularin results in increased expression of BCL2L1 protein CTD PMID:25192816 NSC 23766 multiple interactions EXP 6480464 NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein]] CTD PMID:28268219 Nutlin-3 multiple interactions ISO RGD:735516 6480464 nutlin 3 promotes the reaction [TP53 protein binds to BCL2L1 protein] CTD PMID:16014563 Nutlin-3 decreases expression ISO RGD:735516 6480464 nutlin 3 results in decreased expression of BCL2L1 protein CTD PMID:21109480 ochratoxin A decreases expression ISO RGD:735516 6480464 ochratoxin A results in decreased expression of BCL2L1 mRNA, ochratoxin A results in decreased expression of BCL2L1 protein CTD PMID:15056805 more ... ochratoxin A increases expression ISO RGD:2200 6480464 ochratoxin A results in increased expression of BCL2L1 mRNA CTD PMID:23208426 ochratoxin A decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to ochratoxin A CTD PMID:20549612 oltipraz multiple interactions EXP 6480464 [Lithocholic Acid co-treated with oltipraz] results in increased expression of BCL2L1 mRNA CTD PMID:19433268 oxaliplatin decreases expression ISO RGD:735516 6480464 oxaliplatin results in decreased expression of BCL2L1 protein CTD PMID:16024531 oxybenzone decreases expression ISO RGD:2200 6480464 oxybenzone results in decreased expression of BCL2L1 mRNA CTD PMID:30316929 paclitaxel decreases expression ISO RGD:735516 6480464 Paclitaxel results in decreased expression of BCL2L1 mRNA, Paclitaxel results in decreased expression of BCL2L1 protein CTD PMID:11774260 more ... paclitaxel multiple interactions ISO RGD:735516 6480464 [CXCL8 results in increased expression of BCL2L1 mRNA] which results in decreased susceptibility to Paclitaxel more ... CTD PMID:16051289 more ... paclitaxel decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Paclitaxel CTD PMID:11468182 more ... paclitaxel increases phosphorylation ISO RGD:735516 6480464 Paclitaxel results in increased phosphorylation of BCL2L1 protein CTD PMID:18521433 paclitaxel increases expression ISO RGD:735516 6480464 Paclitaxel results in increased expression of BCL2L1 mRNA, Paclitaxel results in increased expression of BCL2L1 protein CTD PMID:10822281 paracetamol affects expression ISO RGD:735516 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:11896290 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL2L1 mRNA, Acetaminophen results in increased expression of BCL2L1 protein CTD PMID:11264010 , PMID:25743375 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BCL2L1 protein CTD PMID:11461765 more ... paracetamol decreases expression ISO RGD:735516 6480464 Acetaminophen results in decreased expression of BCL2L1 mRNA CTD PMID:21420995 paracetamol multiple interactions ISO RGD:2200 6480464 pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form], Taurine inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] CTD PMID:20166895 paracetamol increases expression ISO RGD:2200 6480464 Acetaminophen results in increased expression of BCL2L1 mRNA, Acetaminophen results in increased expression of BCL2L1 protein modified form CTD PMID:19784758 , PMID:20166895 paracetamol decreases expression ISO RGD:2200 6480464 Acetaminophen results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 paracetamol affects expression ISO RGD:2200 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:19784758 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:17562736 paracetamol multiple interactions EXP 6480464 4-aminobenzamide inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] more ... CTD PMID:10663392 more ... paraquat multiple interactions ISO RGD:735516 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BCL2L1 protein CTD PMID:15824117 paraquat increases expression ISO RGD:735516 6480464 Paraquat results in increased expression of BCL2L1 mRNA, Paraquat results in increased expression of BCL2L1 protein CTD PMID:18056701 paraquat decreases expression ISO RGD:735516 6480464 Paraquat results in decreased expression of BCL2L1 mRNA CTD PMID:18836921 paraquat affects expression ISO RGD:2200 6480464 Paraquat affects the expression of BCL2L1 mRNA CTD PMID:16854511 paraquat decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Paraquat CTD PMID:10970895 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BCL2L1 mRNA, Paraquat results in increased expression of BCL2L1 protein CTD PMID:12595580 , PMID:16797015 paraquat multiple interactions EXP 6480464 GPX1 protein affects the reaction [Paraquat results in increased expression of BCL2L1 protein] CTD PMID:12654481 parathion decreases expression ISO RGD:2200 6480464 Parathion results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 paricalcitol multiple interactions ISO RGD:735516 6480464 [paricalcitol co-treated with arsenic trioxide] results in decreased expression of BCL2L1 CTD PMID:15781666 parthenolide decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to parthenolide CTD PMID:16024633 Pentoxifylline multiple interactions ISO RGD:735516 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein CTD PMID:20804743 Pentoxifylline decreases expression ISO RGD:735516 6480464 Pentoxifylline results in decreased expression of BCL2L1 mRNA, Pentoxifylline results in decreased expression of BCL2L1 protein CTD PMID:18851957 Pepstatin multiple interactions ISO RGD:735516 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 perfluorooctanoic acid increases expression ISO RGD:735516 6480464 perfluorooctanoic acid results in increased expression of BCL2L1 protein CTD PMID:26879310 perindopril multiple interactions ISO RGD:2200 6480464 Perindopril inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:16116328 PHA-665752 decreases expression ISO RGD:735516 6480464 5-((2 more ... CTD PMID:20661229 phenethyl isothiocyanate decreases expression ISO RGD:735516 6480464 phenethyl isothiocyanate results in decreased expression of BCL2L1 protein CTD PMID:16054126 phenobarbital multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BCL2L1 protein CTD PMID:11749691 phenobarbital multiple interactions EXP 6480464 Phenobarbital inhibits the reaction [Lithocholic Acid results in increased expression of BCL2L1 mRNA] CTD PMID:19433268 phenylephrine multiple interactions ISO RGD:2200 6480464 Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 mRNA], Phenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2L1 protein] CTD PMID:11042672 phenylmercury acetate increases expression ISO RGD:735516 6480464 Phenylmercuric Acetate results in increased expression of BCL2L1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735516 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL2L1 mRNA CTD PMID:27188386 phenytoin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 phorbol 13-acetate 12-myristate increases expression ISO RGD:735516 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2L1 protein CTD PMID:11139146 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:735516 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA CTD PMID:18958680 picrotoxin decreases expression ISO RGD:2200 6480464 Picrotoxin results in decreased expression of BCL2L1 mRNA CTD PMID:15170462 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of BCL2L1 mRNA, pirinixic acid results in increased expression of BCL2L1 protein CTD PMID:18445702 , PMID:20709802 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein] CTD PMID:20709802 PK-11195 decreases expression ISO RGD:735516 6480464 PK 11195 results in decreased expression of BCL2L1 protein CTD PMID:15519653 platycodin D decreases expression ISO RGD:735516 6480464 platycodin D results in decreased expression of BCL2L1 protein CTD PMID:23236765 potassium dichromate affects localization ISO RGD:2200 6480464 Potassium Dichromate affects the localization of BCL2L1 protein CTD PMID:21262251 potassium dichromate decreases expression ISO RGD:2200 6480464 Potassium Dichromate results in decreased expression of BCL2L1 protein CTD PMID:21262251 potassium dichromate multiple interactions ISO RGD:2200 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2L1 protein] CTD PMID:21262251 pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of BCL2L1 mRNA] CTD PMID:19433268 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of BCL2L1 mRNA CTD PMID:28903501 prochloraz increases expression ISO RGD:2200 6480464 prochloraz results in increased expression of BCL2L1 mRNA CTD PMID:29038839 progesterone multiple interactions ISO RGD:2200 6480464 BCL2L1 mRNA affects the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]], Mifepristone inhibits the reaction [Progesterone results in increased expression of BCL2L1 protein] CTD PMID:20726854 progesterone increases expression ISO RGD:2200 6480464 Progesterone results in increased expression of BCL2L1 mRNA, Progesterone results in increased expression of BCL2L1 protein CTD PMID:15941375 more ... progesterone affects response to substance ISO RGD:2200 6480464 BCL2L1 mRNA affects the susceptibility to Progesterone CTD PMID:20726854 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of BCL2L1 mRNA CTD PMID:21278054 propofol decreases expression ISO RGD:2200 6480464 Propofol results in decreased expression of BCL2L1 mRNA, Propofol results in decreased expression of BCL2L1 protein CTD PMID:26254736 propylparaben increases expression ISO RGD:735516 6480464 propylparaben results in increased expression of BCL2L1 mRNA, propylparaben results in increased expression of BCL2L1 protein CTD PMID:24481588 prostaglandin E2 multiple interactions ISO RGD:2200 6480464 Dinoprostone affects the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:16396944 protein kinase inhibitor decreases expression ISO RGD:735516 6480464 Protein Kinase Inhibitors results in decreased expression of BCL2L1 protein CTD PMID:21173233 protein kinase inhibitor multiple interactions ISO RGD:735516 6480464 Protein Kinase Inhibitors inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein], Protein Kinase Inhibitors inhibits the reaction [MAP3K20 protein results in decreased expression of BCL2L1 protein] CTD PMID:29105997 pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of BCL2L1 protein CTD PMID:20681671 pterostilbene decreases expression ISO RGD:735516 6480464 pterostilbene results in decreased expression of BCL2L1 protein CTD PMID:23313376 purine-6-thiol decreases expression ISO RGD:735516 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 puromycin multiple interactions ISO RGD:735516 6480464 Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein] CTD PMID:21244482 puromycin decreases expression ISO RGD:735516 6480464 Puromycin results in decreased expression of BCL2L1 protein CTD PMID:21244482 pyrrolidine dithiocarbamate multiple interactions ISO RGD:735516 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:18789402 pyrrolidine dithiocarbamate multiple interactions ISO RGD:2200 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein, Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:18789402 quercetin multiple interactions ISO RGD:735516 6480464 [arsenic trioxide co-treated with Quercetin] results in decreased expression of BCL2L1 protein more ... CTD PMID:16082193 more ... quercetin decreases expression ISO RGD:735516 6480464 Quercetin results in decreased expression of BCL2L1 mRNA, Quercetin results in decreased expression of BCL2L1 protein CTD PMID:16049707 more ... quercetin multiple interactions ISO RGD:2200 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein] CTD PMID:14505808 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [4-nitro-3-cresol results in decreased expression of BCL2L1 protein] more ... CTD PMID:17046822 more ... quercetin increases expression ISO RGD:735516 6480464 Quercetin results in increased expression of BCL2L1 protein CTD PMID:14688022 reactive oxygen species multiple interactions ISO RGD:735516 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of BCL2L1 protein CTD PMID:27634759 Rebamipide multiple interactions ISO RGD:735516 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in increased expression of BCL2L1 protein] more ... CTD PMID:29054700 Rebamipide increases expression ISO RGD:735516 6480464 rebamipide results in increased expression of BCL2L1 protein CTD PMID:29054700 resveratrol multiple interactions ISO RGD:735516 6480464 [clofarabine co-treated with resveratrol] inhibits the reaction [BCL2L1 mutant form results in increased expression of MCL1 protein] more ... CTD PMID:16546976 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of BCL2L1 mRNA CTD PMID:23525482 resveratrol multiple interactions ISO RGD:2200 6480464 resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 resveratrol decreases expression ISO RGD:735516 6480464 resveratrol results in decreased expression of BCL2L1 mRNA, resveratrol results in decreased expression of BCL2L1 protein CTD PMID:11577002 more ... resveratrol decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to resveratrol CTD PMID:19561642 resveratrol increases expression ISO RGD:735516 6480464 resveratrol results in increased expression of BCL2L1 mRNA, resveratrol results in increased expression of BCL2L1 protein CTD PMID:12569576 , PMID:18089832 resveratrol affects localization ISO RGD:2200 6480464 resveratrol affects the localization of BCL2L1 protein CTD PMID:17984113 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of BCL2L1 protein CTD PMID:17872969 resveratrol multiple interactions EXP 6480464 6-chloro-2 more ... CTD PMID:21593185 more ... rifampicin increases expression ISO RGD:735516 6480464 Rifampin results in increased expression of BCL2L1 protein CTD PMID:11958592 , PMID:12645856 rifampicin multiple interactions EXP 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 ritonavir decreases expression ISO RGD:735516 6480464 Ritonavir results in decreased expression of BCL2L1 mRNA CTD PMID:16174765 Ro 31-8220 multiple interactions ISO RGD:2200 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 romidepsin multiple interactions ISO RGD:735516 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2L1 protein CTD PMID:18223231 rotenone affects expression EXP 6480464 Rotenone affects the expression of BCL2L1 mRNA CTD PMID:23186747 rottlerin decreases expression ISO RGD:735516 6480464 rottlerin results in decreased expression of BCL2L1 protein CTD PMID:22902833 rottlerin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]] more ... CTD PMID:25895139 more ... rubimaillin multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP12 protein] more ... CTD PMID:19716835 rutin multiple interactions ISO RGD:2200 6480464 Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA] CTD PMID:26062544 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [Plant Extracts results in decreased expression of BCL2L1 protein] CTD PMID:23993977 Salvianolic acid A multiple interactions ISO RGD:2200 6480464 salvianolic acid A inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:28391263 salvianolic acid B multiple interactions ISO RGD:2200 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 , PMID:24769256 salvianolic acid B increases expression ISO RGD:2200 6480464 salvianolic acid B results in increased expression of BCL2L1 protein CTD PMID:23201927 sarin decreases expression ISO RGD:735516 6480464 Sarin results in decreased expression of BCL2L1 mRNA CTD PMID:19522546 sarin increases expression ISO RGD:735516 6480464 Sarin results in increased expression of BCL2L1 mRNA CTD PMID:19522546 SB 203580 multiple interactions ISO RGD:2200 6480464 SB 203580 promotes the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:19578154 SB 431542 multiple interactions ISO RGD:735516 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL2L1 mRNA CTD PMID:27188386 scutellarin multiple interactions ISO RGD:2200 6480464 scutellarin inhibits the reaction [cobaltous chloride results in decreased expression of BCL2L1 mRNA] CTD PMID:18442013 Se-methyl-L-selenocysteine decreases expression ISO RGD:735516 6480464 selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:25321483 Se-methylselenocysteine decreases expression ISO RGD:735516 6480464 selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:25321483 selenium atom increases expression ISO RGD:735516 6480464 Selenium results in increased expression of BCL2L1 mRNA CTD PMID:19244175 selenium atom multiple interactions ISO RGD:2200 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 senecionine decreases expression ISO RGD:735516 6480464 senecionine results in decreased expression of BCL2L1 protein CTD PMID:29458164 sildenafil citrate multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin], Sildenafil Citrate promotes the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:20884855 sildenafil citrate affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Sildenafil Citrate CTD PMID:20884855 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of BCL2L1 protein CTD PMID:27616297 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of BCL2L1 mRNA CTD PMID:29203145 silicon dioxide multiple interactions EXP 6480464 HMGB1 protein promotes the reaction [Silicon Dioxide results in decreased expression of BCL2L1 protein], neo-gambogic acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2L1 protein] CTD PMID:27616297 simazine decreases expression EXP 6480464 Simazine results in decreased expression of BCL2L1 mRNA CTD PMID:25461544 simvastatin multiple interactions ISO RGD:735516 6480464 Simvastatin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:17277159 simvastatin decreases expression ISO RGD:735516 6480464 Simvastatin results in decreased expression of BCL2L1 protein CTD PMID:18521906 , PMID:20060890 sirolimus multiple interactions ISO RGD:735516 6480464 [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of BCL2L1 protein more ... CTD PMID:15767555 more ... sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of BCL2L1 mRNA, Sirolimus results in increased expression of BCL2L1 protein CTD PMID:18097008 , PMID:21681844 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of BCL2L1 mRNA, Sirolimus results in decreased expression of BCL2L1 protein CTD PMID:19922502 sirolimus multiple interactions EXP 6480464 [Sirolimus co-treated with IL2 protein] results in increased expression of BCL2L1 mRNA, Sirolimus inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:11355896 , PMID:18789402 sirolimus decreases expression ISO RGD:735516 6480464 Sirolimus results in decreased expression of BCL2L1 protein CTD PMID:15782132 sodium arsenite multiple interactions ISO RGD:735516 6480464 LCN2 mutant form inhibits the reaction [sodium arsenite results in increased expression of BCL2L1 mRNA], tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] CTD PMID:24570342 , PMID:26404762 sodium arsenite affects expression ISO RGD:735516 6480464 sodium arsenite affects the expression of BCL2L1 mRNA CTD PMID:29319823 sodium arsenite decreases expression ISO RGD:2200 6480464 sodium arsenite results in decreased expression of BCL2L1 protein CTD PMID:19616567 sodium arsenite multiple interactions ISO RGD:2200 6480464 Taurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein], Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L1 protein alternative form] CTD PMID:19616567 , PMID:20830294 sodium arsenite affects localization EXP 6480464 sodium arsenite affects the localization of BCL2L1 protein CTD PMID:16166651 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BCL2L1 mRNA CTD PMID:16014739 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BCL2L1 mRNA CTD PMID:17451858 sodium arsenite increases expression ISO RGD:2200 6480464 sodium arsenite results in increased expression of BCL2L1 protein CTD PMID:20830294 sodium arsenite decreases expression ISO RGD:735516 6480464 sodium arsenite results in decreased expression of BCL2L1 mRNA, sodium arsenite results in decreased expression of BCL2L1 protein CTD PMID:12760830 , PMID:26404762 sodium arsenite increases expression ISO RGD:735516 6480464 sodium arsenite results in increased expression of BCL2L1 mRNA, sodium arsenite results in increased expression of BCL2L1 protein CTD PMID:24431212 , PMID:24570342 sodium chromate decreases expression ISO RGD:735516 6480464 sodium chromate(VI) results in decreased expression of BCL2L1 mRNA CTD PMID:14971655 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of BCL2L1 protein CTD PMID:20298709 , PMID:21047991 sodium dichromate multiple interactions ISO RGD:735516 6480464 FBP1 protein inhibits the reaction [sodium bichromate results in increased expression of BCL2L1 protein] CTD PMID:28624442 sodium dichromate increases expression ISO RGD:735516 6480464 sodium bichromate results in increased expression of BCL2L1 protein CTD PMID:28624442 sodium dichromate increases expression ISO RGD:2200 6480464 sodium bichromate results in increased expression of BCL2L1 mRNA CTD PMID:12325037 sodium dichromate affects expression ISO RGD:2200 6480464 sodium bichromate affects the expression of BCL2L1 mRNA CTD PMID:11960910 sodium dichromate multiple interactions EXP 6480464 CAT protein inhibits the reaction [sodium bichromate results in decreased expression of BCL2L1 protein], TRP53 mutant form inhibits the reaction [sodium bichromate results in decreased expression of BCL2L1 protein] CTD PMID:20298709 sorafenib multiple interactions ISO RGD:735516 6480464 [sorafenib co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein more ... CTD PMID:17909059 more ... sorafenib decreases expression ISO RGD:735516 6480464 sorafenib results in decreased expression of BCL2L1 protein CTD PMID:16109713 more ... spironolactone increases expression ISO RGD:2200 6480464 Spironolactone results in increased expression of BCL2L1 protein CTD PMID:19114643 stattic multiple interactions ISO RGD:735516 6480464 stattic inhibits the reaction [glycine-extended gastrin 17 results in increased expression of BCL2L1 mRNA] CTD PMID:19153190 staurosporine decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Staurosporine CTD PMID:11468182 staurosporine increases expression ISO RGD:735516 6480464 Staurosporine results in increased expression of BCL2L1 protein alternative form CTD PMID:21256112 staurosporine affects expression ISO RGD:2200 6480464 Staurosporine affects the expression of BCL2L1 mRNA CTD PMID:11296547 staurosporine decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Staurosporine CTD PMID:10970895 staurosporine decreases response to substance EXP 6480464 BCL2L1 protein results in decreased susceptibility to Staurosporine CTD PMID:10679475 stavudine increases expression ISO RGD:2200 6480464 Stavudine results in increased expression of BCL2L1 mRNA CTD PMID:18299183 streptozocin increases expression ISO RGD:2200 6480464 Streptozocin results in increased expression of BCL2L1 protein CTD PMID:15976052 , PMID:19682444 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of BCL2L1 mRNA CTD PMID:24781736 streptozocin decreases expression ISO RGD:2200 6480464 Streptozocin results in decreased expression of BCL2L1 protein CTD PMID:16595661 more ... streptozocin multiple interactions ISO RGD:2200 6480464 Anthocyanins inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] more ... CTD PMID:16595661 more ... styrene increases expression ISO RGD:735516 6480464 Styrene results in increased expression of BCL2L1 protein CTD PMID:16705669 styrene oxide increases expression ISO RGD:735516 6480464 styrene oxide results in increased expression of BCL2L1 protein CTD PMID:16705669 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L1 mRNA CTD PMID:21641980 , PMID:26378955 sulforaphane multiple interactions EXP 6480464 sulforafan inhibits the reaction [sulforafan results in decreased expression of BCL2L1 protein] CTD PMID:21684301 sulforaphane decreases expression ISO RGD:735516 6480464 sulforafan results in decreased expression of BCL2L1 protein CTD PMID:26833863 sulforaphane decreases expression EXP 6480464 sulforafan results in decreased expression of BCL2L1 protein CTD PMID:21684301 sulindac multiple interactions ISO RGD:735516 6480464 [Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein more ... CTD PMID:18281123 sulindac decreases expression ISO RGD:735516 6480464 Sulindac results in decreased expression of BCL2L1 protein CTD PMID:11062132 sulindac sulfide decreases expression ISO RGD:735516 6480464 sulindac sulfide results in decreased expression of BCL2L1 protein CTD PMID:11912124 T-2 Toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of BCL2L1 mRNA, T-2 Toxin results in decreased expression of BCL2L1 protein CTD PMID:29432840 T-2 Toxin affects expression ISO RGD:2200 6480464 T-2 Toxin affects the expression of BCL2L1 protein CTD PMID:29413859 tacrolimus hydrate multiple interactions EXP 6480464 Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 tamoxifen multiple interactions ISO RGD:735516 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2L1 mRNA, [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2L1 protein CTD PMID:22046442 tanespimycin decreases expression ISO RGD:735516 6480464 tanespimycin results in decreased expression of BCL2L1 protein CTD PMID:16923571 taurine multiple interactions ISO RGD:2200 6480464 Taurine inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] more ... CTD PMID:19616567 more ... tauroursodeoxycholic acid decreases expression ISO RGD:2200 6480464 tauroursodeoxycholic acid results in decreased expression of BCL2L1 mRNA CTD PMID:12721362 Tautomycin multiple interactions ISO RGD:735516 6480464 tautomycin inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form], tautomycin inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:18348186 temozolomide multiple interactions ISO RGD:735516 6480464 MGMT protein affects the reaction [BCL2L1 protein affects the susceptibility to temozolomide] CTD PMID:16405512 TEMPO multiple interactions ISO RGD:2200 6480464 TEMPO inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 TEMPO decreases expression EXP 6480464 TEMPO results in decreased expression of BCL2L1 protein CTD PMID:25882087 teriflunomide decreases expression ISO RGD:735516 6480464 A 771726 results in decreased expression of BCL2L1 mRNA CTD PMID:29427785 tert-butyl hydroperoxide multiple interactions ISO RGD:735516 6480464 Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] more ... CTD PMID:26102008 , PMID:27050144 tert-butyl hydroperoxide decreases expression ISO RGD:2200 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein CTD PMID:15569404 tert-butyl hydroperoxide multiple interactions ISO RGD:2200 6480464 Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] CTD PMID:15569404 tert-butyl hydroperoxide decreases expression ISO RGD:735516 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA, tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein CTD PMID:12419474 more ... testosterone increases expression ISO RGD:2200 6480464 Testosterone results in increased expression of BCL2L1 mRNA, Testosterone results in increased expression of BCL2L1 protein CTD PMID:23500659 , PMID:25714330 testosterone multiple interactions ISO RGD:2200 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein], resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 tetrachloromethane increases expression ISO RGD:2200 6480464 Carbon Tetrachloride results in increased expression of BCL2L1 mRNA, Carbon Tetrachloride results in increased expression of BCL2L1 protein CTD PMID:16038630 , PMID:26062544 tetrachloromethane decreases expression ISO RGD:2200 6480464 Carbon Tetrachloride results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 tetrachloromethane affects expression ISO RGD:2200 6480464 Carbon Tetrachloride affects the expression of BCL2L1 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions EXP 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA] CTD PMID:18038451 tetrachloromethane multiple interactions ISO RGD:2200 6480464 [Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of BCL2L1 mRNA more ... CTD PMID:17069928 more ... tetramethylpyrazine multiple interactions ISO RGD:2200 6480464 tetramethylpyrazine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] CTD PMID:17132701 tetramethylpyrazine multiple interactions ISO RGD:735516 6480464 tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] CTD PMID:26404762 thalidomide decreases expression ISO RGD:735516 6480464 Thalidomide results in decreased expression of BCL2L1 protein CTD PMID:15986355 thapsigargin multiple interactions ISO RGD:735516 6480464 BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of ERN1 protein], BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein alternative form] CTD PMID:23885834 thapsigargin affects splicing ISO RGD:2200 6480464 Thapsigargin affects the splicing of BCL2L1 mRNA CTD PMID:25762722 thapsigargin affects splicing EXP 6480464 Thapsigargin affects the splicing of BCL2L1 mRNA CTD PMID:25762722 thapsigargin multiple interactions ISO RGD:2200 6480464 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA] more ... CTD PMID:25762722 thapsigargin increases expression ISO RGD:2200 6480464 Thapsigargin results in increased expression of BCL2L1 protein CTD PMID:25762722 thioacetamide decreases expression ISO RGD:2200 6480464 Thioacetamide results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 thioacetamide multiple interactions ISO RGD:2200 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 thiostrepton decreases expression ISO RGD:735516 6480464 Thiostrepton results in decreased expression of BCL2L1 mRNA CTD PMID:22321511 Thiotepa increases expression ISO RGD:735516 6480464 Thiotepa results in increased expression of BCL2L1 protein CTD PMID:10822281 thymol multiple interactions ISO RGD:2200 6480464 Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] CTD PMID:26996544 thymol sulfate(1-) multiple interactions ISO RGD:2200 6480464 Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] CTD PMID:26996544 tin dichloride (anh.) multiple interactions ISO RGD:2200 6480464 [stannous chloride results in increased activity of HMOX1 protein] which results in increased expression of BCL2L1 protein CTD PMID:16959961 titanium dioxide decreases expression ISO RGD:735516 6480464 titanium dioxide results in decreased expression of BCL2L1 mRNA CTD PMID:19486931 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of BCL2L1 mRNA CTD PMID:23409001 , PMID:27760801 tocopherol decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 topotecan multiple interactions EXP 6480464 APAF1 promotes the reaction [Topotecan results in increased degradation of BCL2L1 protein] more ... CTD PMID:19812371 topotecan increases degradation EXP 6480464 Topotecan results in increased degradation of BCL2L1 protein CTD PMID:19812371 tributylstannane multiple interactions EXP 6480464 PRKCD gene mutant form inhibits the reaction [tributyltin results in decreased expression of BCL2L1 protein] CTD PMID:25895139 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BCL2L1 mRNA CTD PMID:22434021 Tributyltin oxide decreases expression ISO RGD:735516 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BCL2L1 mRNA CTD PMID:21601586 trichloroethene multiple interactions ISO RGD:2200 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 trichostatin A multiple interactions ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to [Bortezomib co-treated with trichostatin A] more ... CTD PMID:16904634 , PMID:19887557 trichostatin A affects expression ISO RGD:735516 6480464 trichostatin A affects the expression of BCL2L1 mRNA CTD PMID:28542535 trichostatin A decreases expression ISO RGD:2200 6480464 trichostatin A results in decreased expression of BCL2L1 mRNA CTD PMID:23558232 trichostatin A decreases expression ISO RGD:735516 6480464 trichostatin A results in decreased expression of BCL2L1 protein CTD PMID:16009488 , PMID:19887557 trichostatin A decreases response to substance ISO RGD:2200 6480464 BCL2L1 gene mutant form results in decreased susceptibility to trichostatin A CTD PMID:10970895 trichostatin A decreases response to substance ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to trichostatin A CTD PMID:15781649 trimethyltin decreases expression EXP 6480464 trimethyltin results in decreased expression of BCL2L1 protein CTD PMID:25895139 trimethyltin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]], rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein] CTD PMID:25895139 Triptolide increases expression EXP 6480464 triptolide results in increased expression of BCL2L1 protein CTD PMID:26990902 Triptolide multiple interactions EXP 6480464 TRP53 gene mutant form inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein] CTD PMID:30009776 Triptolide decreases expression ISO RGD:2200 6480464 triptolide results in decreased expression of BCL2L1 protein CTD PMID:30009776 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of BCL2L1 protein CTD PMID:30009776 Triptolide multiple interactions ISO RGD:2200 6480464 pifithrin inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein] CTD PMID:30009776 troglitazone decreases expression ISO RGD:735516 6480464 troglitazone results in decreased expression of BCL2L1 mRNA, troglitazone results in decreased expression of BCL2L1 protein CTD PMID:12680223 , PMID:19631733 tunicamycin decreases expression ISO RGD:735516 6480464 Tunicamycin results in decreased expression of BCL2L1 mRNA CTD PMID:22378314 Tylophorine increases expression ISO RGD:735516 6480464 tylophorine analog results in increased expression of BCL2L1 mRNA CTD PMID:19284764 tyrphostin AG 1478 decreases expression ISO RGD:2200 6480464 RTKI cpd results in decreased expression of BCL2L1 mRNA, RTKI cpd results in decreased expression of BCL2L1 protein CTD PMID:18371937 valproic acid decreases methylation ISO RGD:735516 6480464 Valproic Acid results in decreased methylation of BCL2L1 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:735516 6480464 Valproic Acid results in decreased expression of BCL2L1 protein CTD PMID:22814014 valproic acid increases expression ISO RGD:735516 6480464 Valproic Acid results in increased expression of BCL2L1 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions EXP 6480464 ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to Valproic Acid] CTD PMID:19060243 valproic acid decreases response to substance EXP 6480464 BCL2L1 protein results in decreased susceptibility to Valproic Acid CTD PMID:19060243 veliparib multiple interactions ISO RGD:735516 6480464 BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 vemurafenib multiple interactions ISO RGD:735516 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BCL2L1 mRNA CTD PMID:27169980 vinclozolin increases expression ISO RGD:2200 6480464 vinclozolin results in increased expression of BCL2L1 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:735516 6480464 Vincristine results in increased expression of BCL2L1 mRNA CTD PMID:23649840 vincristine affects response to substance ISO RGD:735516 6480464 BCL2L1 protein affects the susceptibility to Vincristine CTD PMID:22178383 vitamin E decreases expression ISO RGD:2200 6480464 alpha-Tocopherol results in decreased expression of BCL2L1 protein CTD PMID:18942769 vitamin E increases expression ISO RGD:735516 6480464 Vitamin E results in increased expression of BCL2L1 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:2200 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 vorinostat multiple interactions ISO RGD:2200 6480464 [vorinostat co-treated with MYC protein] results in decreased expression of BCL2L1 mRNA, [vorinostat co-treated with MYC protein] results in decreased expression of BCL2L1 protein CTD PMID:17331788 vorinostat decreases response to substance EXP 6480464 BCL2L1 protein results in decreased susceptibility to vorinostat CTD PMID:19060243 vorinostat increases expression ISO RGD:735516 6480464 vorinostat results in increased expression of BCL2L1 mRNA alternative form, vorinostat results in increased expression of BCL2L1 protein alternative form CTD PMID:17351739 vorinostat multiple interactions EXP 6480464 ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to vorinostat] CTD PMID:19060243 vorinostat decreases response to substance ISO RGD:735516 6480464 BCL2L1 results in decreased susceptibility to vorinostat CTD PMID:10597302 vorinostat decreases expression ISO RGD:2200 6480464 vorinostat results in decreased expression of BCL2L1 protein CTD PMID:18310471 vorinostat decreases expression ISO RGD:735516 6480464 vorinostat results in decreased expression of BCL2L1 mRNA more ... CTD PMID:15897598 more ... vorinostat multiple interactions ISO RGD:735516 6480464 [(+)-JQ1 compound co-treated with vorinostat] results in decreased expression of BCL2L1 protein more ... CTD PMID:12446442 more ... wortmannin multiple interactions ISO RGD:735516 6480464 wortmannin inhibits the reaction [Hydrogen Peroxide inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein]] CTD PMID:15142122 zerumbone decreases expression ISO RGD:735516 6480464 zerumbone results in decreased expression of BCL2L1 mRNA CTD PMID:16007145 zinc atom decreases expression ISO RGD:735516 6480464 Zinc results in decreased expression of BCL2L1 protein CTD PMID:16472982 zinc atom multiple interactions ISO RGD:735516 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zinc atom increases expression ISO RGD:2200 6480464 Zinc results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc dichloride multiple interactions ISO RGD:735516 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein CTD PMID:16624386 zinc protoporphyrin multiple interactions ISO RGD:2200 6480464 zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of BCL2L1 protein] CTD PMID:20357190 zinc protoporphyrin increases expression ISO RGD:735516 6480464 zinc protoporphyrin results in increased expression of BCL2L1 protein CTD PMID:27829220 zinc pyrithione decreases expression ISO RGD:735516 6480464 pyrithione zinc results in decreased expression of BCL2L1 mRNA CTD PMID:21424779 zinc sulfate increases expression ISO RGD:2200 6480464 Zinc Sulfate results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc sulfate multiple interactions ISO RGD:735516 6480464 [Zinc Sulfate binds to azilsartan] which results in decreased expression of BCL2L1 protein CTD PMID:29408668 zinc(0) decreases expression ISO RGD:735516 6480464 Zinc results in decreased expression of BCL2L1 protein CTD PMID:16472982 zinc(0) increases expression ISO RGD:2200 6480464 Zinc results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc(0) multiple interactions ISO RGD:735516 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zoledronic acid increases expression ISO RGD:735516 6480464 zoledronic acid results in increased expression of BCL2L1 mRNA CTD PMID:19036117 zolmitriptan multiple interactions ISO RGD:2200 6480464 zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA], zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:31129132
Gene-Chemical Interaction Annotations